properties and units in the clinical...

Pure Appl. Chem., Vol. 72, No. 3, pp. 479–552, 2000.© 2000 IUPAC

Republication or reproduction of this report or its storage and/or dissemination by electronic means is permitted without theneed for formal IUPAC permission on condition that an acknowledgment, with full reference to the source, along with use of thecopyright symbol ©, the name IUPAC, and the year of publication, are prominently visible. Publication of a translation intoanother language is subject to the additional condition of prior approval from the relevant IUPAC National AdheringOrganization.

479

INTERNATIONAL FEDERATION OF CLINICAL CHEMISTRY AND LABORATORYMEDICINE

SCIENTIFIC DIVISIONCOMMITTEE ON NOMENCLATURE, PROPERTIES, AND UNITS (C-NPU)#

and

INTERNATIONAL UNION OF PURE AND APPLIED CHEMISTRY

CHEMISTRY AND HUMAN HEALTH DIVISIONCLINICAL CHEMISTRY SECTION

COMMISSION ON NOMENCLATURE, PROPERTIES, AND UNITS (C-NPU)§

PROPERTIES AND UNITS IN THE CLINICALLABORATORY SCIENCES

PART XII. PROPERTIES AND UNITS IN CLINICALPHARMACOLOGY AND TOXICOLOGY

(Technical Report)

(IFCC–IUPAC 1999)

Prepared for publication byHENRIK OLESEN1, DAVID COWAN2, RAFAEL DE LA TORRE3 ,

IVAN BRUUNSHUUS1, MORTEN ROHDE1, and DESMOND KENNY4

1Office of Laboratory Informatics, Copenhagen University Hospital (Rigshospitalet),Copenhagen, Denmark; 2Drug Control Centre, London University, King’s College, London,

UK; 3IMIM, Dr. Aiguader 80, Barcelona, Spain; 4Dept. of Clinical Biochemistry, OurLady’s Hospital for Sick Children, Crumlin, Dublin 12, Ireland

#§The combined Memberships of the Committee and the Commission (C-NPU) during the preparation of thisreport (1994–1996) were as follows:Chairman: H. Olesen (Denmark, 1989–1995); D. Kenny (Ireland, 1996); Members: X. Fuentes-Arderiu (Spain,1991–1997); J. G. Hill (Canada, 1987–1997); D. Kenny (Ireland, 1994–1997); H. Olesen (Denmark, 1985–1995);P. L. Storring (UK, 1989–1995); P. Soares de Araujo (Brazil, 1994–1997); R. Dybkær (Denmark, 1996–1997); C.McDonald (USA, 1996–1997).

Please forward comments to:H. Olesen, Office of Laboratory Informatics 76-6-1, Copenhagen University Hospital (Rigshospitalet),9 Blegdamsvej, DK-2100 Copenhagen, Denmark. E-mail: [email protected]

480 H. OLESEN

© 2000 IUPAC, Pure and Applied Chemistry 72, 479–552

Properties and units in the clinical laboratorysciences.Part XII. Properties and units in clinicalpharmacology and toxicology(Technical Report)

Abstract: The term designating a substance being an active ingredient of a drugmay be a generic name, a nonproprietary name, a registered trade name, a fantasyname, or other. This causes difficulties in the transmission of requests and reportson properties for such substances in biological fluids to and from the clinicallaboratories, and in the collating of this information from different sources.

The document comprises a list of properties of drugs in biological fluids foruse in electronic transmission systems. Systematic names are presented togetherwith a code value for each.

PREFACE

The present document is part twelve (XII) of a series on properties and units in the clinical laboratorysciences initiated in 1987.

The series will comprise:

I. Syntax and semantic rules [1]II. Kinds-of-property [2]III. Elements (of properties) and their code valuesIV. Properties and their code valuesV. Properties and units in thrombosis and haemostasisVI. Properties and units in IOC-prohibited drugsVII. Properties and units in inborn errors of metabolismVIII. Properties and units in clinical microbiologyIX. Properties and units in trace elementsX. Properties and units in general clinical chemistryXI. Coding systems: structure and guidelines [3]XII. Properties and units in clinical pharmacology and toxicology (this report)XIII. Properties and units in reproduction and fertilityXVI. Properties and units in clinical allergology

The size and complexity of parts III and IV are such that their lists will be presented in electronicformat. This is for ease of handling and to facilitate expression of concepts in different languages.

At the end, systematic names, elaborated according to international standards and recommenda-tions, should be available in the different domains of clinical laboratory sciences. The core of the seriesis code value strings representing concepts, that in combination delineate and define each propertyregardless of linguistic expression, thus avoiding errors during translation between languages.

Properties and units in clinical pharmacology and toxicology 481


FOREWORD AND SCOPE

Clinical laboratory sciences are characterized by the exacting nature of the work performed and thedemand for an accurate presentation of the outcome. Furthermore, the domain is transnational,international, or “global”.

The adherent informatics system therefore needs to identify the findings accurately and to presentthem with the degree of detail required. At the same time it has to facilitate the transfer over linguisticand cultural barriers without distortion or loss of clarity, in order to promote clear, unambiguous, mean-ingful, and fully informative communication in different terminologies.

The degree to which a message (such as a laboratory report) needs to be expressed in a formal,systematic language depends on the geographical, linguistic, social or professional distance betweenthe communicating parties. The greater the distance, the greater the risk of misunderstanding.

Within one laboratory, local jargon terms may be used which are usually well understood be-tween colleagues, but which would not be sufficiently widely known for communication with the out-side world. Likewise, a laboratory and its local community of users, such as hospital or communityphysicians, may use a “local dialect” of the language of clinical laboratory sciences which is wellunderstood by all concerned; but when the communication possibilities are wider, even transnational,risks of serious misunderstanding arise.

The purpose of this document is to apply the IFCC–IUPAC recommended syntax structures forrequest and report and to create a systematic terminology that can be used as the basis for encodinglaboratory messages in the domain of drugs. The systamatic names recommended here are primarily forthe purpose of unambiguous data exchange. Their use in routine language by clinician or laboratorypractitioners is optional but encouraged.

DEFINITIONS

component definable part of a system [ENV 1614; 4]EXAMPLE: Dextropropoxyphene as part of a plasma sample

discrimination value value of a quantity established from purpose related considerationsNOTE: The term cut-off value is used as a synonym.

detection limit result of a measurement by a given measurement procedure for which theprobability of an analytically false negative result is b, given the probabilitya of an analytically false positive result [5]

drug substance which when absorbed into a living organism may modify one ormore of its functions [6]NOTE: The term is generally accepted for a substance taken for a therapeu-tic purpose, but is also commonly used for abused substances.

kind-of-property attribute of phenomena, bodies or substances that may distinguishedqualitatively [after ENV 1614; 4]NOTE 1: In ENV 1614 the term “property” (in a general sense) is used as asynonym for kind-of-property.NOTE 2: A kind-of-property may be related to nominal scale (e.g., green;blue), ordinal scale (e.g., small; large), difference scale [e.g., 10 °C (i.e.,10 °C more than an arbitrary zero)] or ratio scale (length 2 m or 5 m); thelast two types of kind-of-property are also called kind-of-quantity.

482 H. OLESEN


nominal scale scale with a set of possible values for a given kind-of-property that are eacha word or symbol without any relation to magnitude [5]EXAMPLE: Names of analgesic drugs.NOTE: The values may be listed in any arbitrary order according topractical considerations and convention.

ordinal scale scale with an ordered set of possible values for a given kind-of-property thatare each a word or symbol used for ranking according to magnitude, butwhere differences or ratios between values have no arithmetic meaning [5]EXAMPLE: arbitrary concentration of cannabinoid in urine (“not de-tected”; “detected” or 0 1).

difference scale scale with an ordered set of possible values of a given kind of measurablequantity that are each a product of numerical value and unit of measurementsuch that a given difference between values corresponds to the samedifference between magnitudes of the measurable quantities along the scale[5]EXAMPLE: (substance concentration increment) –32 µmol/l

property set of data elements comprising information on system, component, andkind-of-property and their adherent specifications.NOTE 1: There is presently no officially approved definition of thisconcept. The present definition is for use in this document only.NOTE 2: Information about identification of system, time, and result is notconsidered.EXAMPLE: substance concentration of fentanyl in blood plasma.

ratio scale scale of measurement with an ordered set of values for a given kind ofmeasurable quantity that are each a product of numerical value and unit ofmeasurement such that a given ratio between values corresponds to thesame ratio between magnitudes of the measurable quantities along the scale[5]EXAMPLE: 0 0,1 0,2 - - - 31 32 µmol/l.

system demarcated arrangement of a set of elements and a set of relationshipsbetween these elements [ENV 1614; 4].EXAMPLE: a portion of urine, a portion of blood.

SYSTEMATIC REQUEST AND REPORT OF CLINICAL LABORATORY RESULTS

By convention, properties and results of examinations are represented by the equation:

Equation 1Property = Result

The parts comprised in the concept of ‘property’ and in the concept of ‘result’ are presented inTable 1.



• Essential for a request is parts 1 and 2, that is information on patient identification, time or timeinterval for sampling, and information on the property requested.

• The laboratory report on a particular property comprises the three parts 1, 2, and 3.

• To each element in part 2 may be added a specification as a parenthetic suffix for clarification,identification, and to avoid ambiguity.

• Note(s) (part 4) relating to, for example, diagnosis, medication, haemolysis, or hardware break-down are not included, except when needed for the interpretation of results such as pretreatmentof patient or subject.

• Thus, the elements of a term for a type of property comprise: System(specification)—Component(specification); kind-of-property(specification)

• This is as recommended by IFCC and IUPAC (3) and by the European standard ENV 1614:1995[4].

• EXAMPLE [NPU02164]Plasma—Gentamicin; substance concentration

• The elements of a result comprise: an operator (= < £ > ≥ etc.), a numerical value and a unit,usually in symbolic form. This is as recommended by the European standard ENV 12435:1996[7]

• EXAMPLE [NPU02164]= 6 µmol/l (prefix µ: micro = 10–6)

• Nominal and ordinal scale values carry no unit. In difference and ratio scales the unit must neverbe omitted in reporting results, except for the unit 1.

• It is further recommended that the result includes or refers to a value for a measure of uncertainty[7].

• The names of components are from the International Nonproprietary Names (INN) of WHO [8]for pharmaceutical substances (English, French, Russian and Spanish). If not recorded in INN,preference is for CAS trivial names [9], USAN [10], BAN [11], Martindale [12], in that sequence.

• In addition to the systematic name of the property, an example and other useful information aregiven.

Table 1 Systematic request and report.

1 Identification and time1.1 Object or patient identification1.2 Date and time(s) of sampling

2 Property2.1 System2.2 Component2.3 Kind-of-property

3 Result3.1 Equality, inequality or other operator3.2 Value (for quantities on a difference or ratio scale, a numerical value multiplied by a unit)

4 Notes

484 H. OLESEN


For details, see IUPAC–IFCC (Recommendations 1995). Syntax and semantic rules [1].Most drugs are metabolized by the organism. Therefore, the analytical findings pertain to the

drug administered and to its metabolites. Often the non-modified drug is hardly detectable. If so, theresult given to the requester is on the parent compound in the form of a result deduced from the presenceof specific metabolites. Information on metabolites found is part of the report and is given after a“deduced from”.

ELEMENTS OF AN ENTRY

The terms recommended are given in bold, that is: the systematic term for the type of property, the unitand the code value.

1. Name of system and parenthetic specification spelled out in full, and followed by a long dash(em dash).

2. Alphanumeric chemical prefixes to component name.3. Recommended name of component and parenthetic specification. Shifted to the left for al-

phabetical sorting and searching, and followed by a semicolon.4. Kind-of-property and parenthetic specification.5. Unit.6. Other term(s).7. Authority: Code value for the international organization recommending the name of the compo-

nent or the combined elements of an entry.8. Note(s) with any further information.9. [NPUXXXXX]

Coding scheme identifier and code value, intended for interlaboratory transmission betweendatabases.

10. Example in abbreviated form.

The term “arbitrary” in princible cannot be related to a volume. In clinical chemistry, however, aless well defined “inhouse” or a regional calibrator is often referred to and is expressed in “arbitrary unitper liter” in order to enable comparison of patient data over time and regionally. In each of these in-stances further information should be given in the parenthesis “procedure”. This could be informationon the calibrator used, f.ex. “BCR/CRM148/149R“ or it could refer to the inlaboratory document“procedure xx”, which is available on request.

In the examples given, a question mark, “?”, has been used to represent the value of a result forproperties including quantities.

EXAMPLES

a. Nominal scale

1. Urine—3. Analgesic drug;4. taxon(procedure)9. [NPU04479]10. U—Analgesic drug; taxon(Firm xxx) = Buprenorphine; Dextropropoxyphene



1. Urine—3. Narcotic drug;4. taxon(procedure)9. [NPU08930]10. U—Narcotic drug; taxon(Firm xxx) = Cocaine

deduced fromBenzoylecgonine (CAS519-09-5)Ecgonine (CAS481-37-8)

b. Ordinal scaleIn the actual reporting the possible scale values should be listed in the parenthesis after thekind-of-property.

1. Urine—3. Analgesic drug;4. arbitrary concentration(list; procedure)9. [NPU04845]10. U—Analgesic drug; arb.c.(list; 0 1)

[NPU04934] U—Alphaprodine; arb.c.(0 1) = 0[NPU04401] U—Anileridine; arb.c.(0 1) = 0[NPU04584] U—Buprenorphine; arb.c.(0 1) = 1[NPU01710] U—Codeine; arb.c.(0 1) = 0[NPU04916] U—Dextromoramide; arb.c.(0 1) = 0[NPU01866] U—Dextropropoxyphene; arb.c.(0 1) = 1[NPU04450] U—Diamorphine; arb.c.(0 1) = 0[NPU04454] U—Dipipanone; arb.c.(0 1) = 0[NPU04463] U—Ethoheptazine; arb.c.(0 1) = 0[NPU04464] U—Ethylmorphine; arb.c.(0 1) = 0[NPU02032] U—Fentanyl; arb.c.(0 1) = 0[NPU02408] U—Hydrocodone; arb.c.(0 1) = 0[NPU02523] U—Ketobemidone; arb.c.(0 1) = 0[NPU04497] U—Levorphanol; arb.c.(0 1) = 0[NPU02722] U—Methadone; arb.c.(0 1) = 0[NPU02846] U—Morphine(non-complexed); arb.c.(0 1) = 0[NPU04536] U—Nalbuphine; arb.c.(0 1) = 0[NPU04591] U—Oxycodone; arb.c.(0 1) = 0[NPU04596] U—Paracetamol; arb.c.(0 1) = 0[NPU03035] U—Pentazocine; arb.c.(0 1) = 0[NPU03049] U—Pethidine; arb.c.(0 1) = 0[NPU04599] U—Phenazocine; arb.c.(0 1) = 0[NPU03384] U—Salicylate; arb.c.(0 1) = 0[NPU04549] U—Tramadol; arb.c.(0 1) = 0[NPU04647] U—Trimeperidine; arb.c.(0 1) = 0

1. Urine—3. Cocaine;4. arbitrary concentration(procedure)

486 H. OLESEN


7. Authority: BAN9. [NPU01706]10. U—Cocaine; arb.c.(0 1) = 1

deduced fromBenzoylecgonine (CAS519-09-5)Ecgonine (CAS481-37-8)

c. Ratio scale

1. Plasma—3. Fentanyl;4. substance concentration5. nanomole/liter9. [NPU08918]10. P—Fentanyl; subst.c. = ? nmol/l

REFERENCES

1. Commission/Committee on Quantities and Units (in Clinical Chemistry) of the IUPAC–IFCC(International Union of Pure and Applied Chemistry– International Federation of ClinicalChemistry). Properties and units in the clinical laboratory sciences. I. Syntax and semantic rules.Prepared for publication by H. Olesen. Pure Appl. Chem. 67, 1563–74 (1995); Eur. J. Clin. Chem.Clin. Biochem. 33, 627–36 (1995); Clin. Chim. Acta 245, S5–S21 (1996).

2. Commission/Committee on Quantities and Units (in Clinical Chemistry) of the IUPAC–IFCC(International Union of Pure and Applied Chemistry–International Federation of ClinicalChemistry). Properties and units in the clinical laboratory sciences. II. Kinds-of-property. Preparedfor publication by D. Kenny and H. Olesen. Eur. J. Clin. Chem. Clin. Biochem. 35, 317–44 (1997).

3. Commission/Committee on Nomenclature, Properties and Units of the IUPAC–IFCC (InternationalUnion of Pure and Applied Chemistry–International Federation of Clinical Chemistry). Propertiesand units in the clinical laboratory sciences. XI. Coding systems—structure and guidelines.(Technical report 1997). Prepared for publication by H. Olesen, D. Kenny, R. Dybkær, I. Ibsen, I.Bruunshuus, X. Fuentes-Arderiu, G. Hill, P. Soares de Araujo, C. McDonald. Pure Appl. Chem.35, 317–44 (1997).

4. CEN/TC 251,1995. European Prestandard ENV 1614. Medical informatics. Structure fornomenclature, classification and coding of properties in clinical laboratory sciences.

5. R. Dybkaer. Eur. J. Clin. Chem. Clin. Biochem. 35 (2), 141–73 (1997).6. J. H. Duffus. Pure and Appl. Chem. 65, 2003–2122 (1993).7. CEN/TC 251, 1996. European Prestandard, ENV 12435. Medical informatics. Expression of the

results of measurement in health sciences.8. WHO. International Nonproprietary Names (INN) for Pharmaceutical Substances. Geneva: WHO.9. CAS Registry Number.

10. USAN (U.S. Adopted Name). 1961–1987 Cumulative List. List 147-289.11. BAN (British Approved Names) booklet, 1986, 1st, 2nd, 3rd, and 4th supplements.12. E. F. Reynolds (Ed.). Martindale. The Extra Pharmacopoeia, 31st ed., London, The Pharmaceutical

Press (1996).



INDEX OF ABBREVIATIONS

BAN British Approved NameCAS Chemical Abstracts ServiceIFCC International Federation of Clinical Chemistry and Laboratory MedicineINN International Nonproprietary Names of WHO (approved)*INN for name to be approvedISO International Organization for StandardizationIUPAC International Union of Pure and Applied ChemistryUSAN United States Adopted NameWHO World Health Organization

LIST OF PROPERTIES IN PHARMACOLOGY AND TOXICOLOGY

Urine—Acebutolol;

arbitrary concentration(procedure)M = 336,43 g/molNPU04576U—Acebutolol; arb.c.(proc.) = ?

Urine—Acebutolol;

substance concentrationmicromole/literM = 336,43 g/molNPU01003U—Acebutolol; subst.c. = ? µmol/l

Plasma—Acecainide;

substance concentrationmicromole/literNPU10765P—Acecainide; subst.c. = ? µmol/l

Urine—Acepromazine;

arbitrary concentration(procedure)M = 326,47 g/molNPU04328U—Acepromazine; arb.c.(proc.) = ?

Plasma—Acepromazine;

substance concentrationmicromole/literM = 326,47 g/molNPU01004P—Acepromazine; subst.c. = ? µmol/l

Urine—Acepromazine;

substance concentrationmicromole/literM = 326,47 g/molNPU04329U—Acepromazine; subst.c. = ? µmol/l

Urine—Acetazolamide;

arbitrary concentration(procedure)M = 222,25 g/molNPU08917U—Acetazolamide; arb.c.(proc.) = ?

Plasma—Acetazolamide;

substance concentrationmicromole/literM = 222,25 g/molNPU04624P—Acetazolamide; subst.c.= ? µmol/l

Urine—Acetazolamide;

substance concentrationmicromole/literM = 222,25 g/molNPU01009U—Acetazolamide; subst.c. = ? µmol/l


488 H. OLESEN

Urine—Adrenergic beta-antagonist;

arbitrary concentration(list; procedure)Other term(s): Beta-Antagonist, adrenergic;Beta-Adrenergic receptor blockader; Beta-Adrenergic blocking agent; Beta-blocker,adrenergic; Beta-blocking drugNPU04413U—Adrenergic beta-antagonist; arb.c.(list;proc.)NPU04576 U—Acebutolol; arb.c.(proc.) = ?NPU04577 U—Alprenolol; arb.c.(proc.) = ?NPU04579 U—Atenolol; arb.c.(proc.) = ?NPU04405 U—Betaxolol; arb.c.(proc.) = ?NPU04406 U—Bevantolol; arb.c.(proc.) = ?NPU04407 U—Bisoprolol; arb.c.(proc.) = ?NPU04962 U—Bupranolol; arb.c.(proc.) = ?NPU04960 U—Bunitrolol; arb.c.(proc.) = ?NPU04961 U—Bunolol; arb.c.(proc.) = ?NPU14146 U—Carteolol; arb.c.(proc.) = ?NPU04697 U—Labetalol; arb.c.(proc.) = ?NPU04503 U—Mepindolol; arb.c.(proc.) = ?NPU04616 U—Metoprolol; arb.c.(proc.) = ?NPU04555 U—Nadolol; arb.c.(proc.) = ?NPU04542 U—Nifenalol; arb.c.(proc.) = ?NPU04620 U—Oxprenolol; arb.c.(proc.) = ?NPU04621 U—Penbutolol; arb.c.(proc.) = ?NPU04626 U—Pindolol; arb.c.(proc.) = ?NPU03231 U—Practolol; arb.c.(proc.) = ?NPU03266 U—Propranolol; arb.c.(proc.) = ?NPU08674 U—Sotalol; arb.c.(proc.) = ?NPU14147 U—Tertatolol; arb.c.(proc.) = ?NPU04629 U—Timolol; arb.c.(proc.) = ?

Urine—Adrenergic beta-antagonist;

taxon(procedure)Other term(s): Beta-Antagonist, adrenergic;Beta-Adrenergic receptor blockader; Beta-Adrenergic blocking agent; Beta-blocker,adrenergic; Beta-blocking drugNPU04414U—Adrenergic beta-antagonist; taxon(proc.)=?

Urine—Alfentanil;

arbitrary concentration(procedure)M = 416,52 g/molNPU04330U—Alfentanil; arb.c.(proc.) = ?

Plasma—Alfentanil;

substance concentrationmole/literM = 416,52 g/molNPU04554P—Alfentanil; subst.c.= ? prefix ? mol/l

Urine—Alfentanil;

substance concentrationmole/literM = 416,52 g/molNPU04331U—Alfentanil; subst.c.= ? prefix ? mol/l

Plasma—Alimemazine;

substance concentrationnanomole/literNPU08965P—Alimemazine; subst.c. = ? nmol/l

Urine—Allopurinol;

arbitrary concentration(procedure)M = 136,11 g/molNPU04332U—Allopurinol; arb.c.(proc.) = ?

Plasma—Allopurinol;

substance concentrationmole/literM = 136,11 g/molNPU04334P—Allopurinol; subst.c.= ? prefix ? mol/l

Urine—Allopurinol;

substance concentrationmole/literM = 136,11 g/molNPU04333U—Allopurinol; subst.c.= ? prefix ? mol/l

Urine—Alphaprodine;

arbitrary concentration(procedure)M = 261,35 g/molOther term(s): AlphaprodineNPU04934U—Alphaprodine; arb.c.(proc.) = ?

Urine—Alphaprodine;

substance concentrationmicromole/literM = 261,35 g/molOther term(s): AlphaprodineNPU01150U—Alphaprodine; subst.c. = ? µmol/l



Urine—Alprazolam;

arbitrary concentration(procedure)M = 308,77 g/molNPU01151U—Alprazolam; arb.c.(proc.) = ?

Urine—Alprazolam;

substance concentrationmicromole/literM = 308,77 g/molNPU04335U—Alprazolam; subst.c. = ? µmol/l

Plasma—Alprazolam;

substance concentrationnanomole/literM = 308,77 g/molNPU04627P—Alprazolam; subst.c.= ? nmol/l

Urine—Alprenolol;

arbitrary concentration(procedure)M = 249,35 g/molNPU04577U—Alprenolol; arb.c.(proc.) = ?

Urine—Alprenolol;

substance concentrationmicromole/literM = 249,35 g/molNPU01154U—Alprenolol; subst.c. = ? µmol/l

Plasma—Amantadine;

substance concentrationmicromole/literM = 151,26 g/molNPU04336P—Amantadine; subst.c. = ? µmol/l

Urine—Amantadine;

substance concentrationmicromole/literM = 151,26 g/molNPU04337U—Amantadine; subst.c. = ? µmol/l

Urine—Amdinocillin;

arbitrary concentration(procedure)M = 325,43 g/molNPU10187U—Amdinocillin; arb.c.(proc.) = ?

Urine—Amfebutamone;

arbitrary concentration(procedure)M = 239,74 g/molNPU04344U—Amfebutamone; arb.c.(proc.) = ?

Plasma—Amfebutamone;

substance concentrationmole/literM = 239,74 g/molOther term(s): BupropionNPU04346P—Amfebutamone; subst.c.= ? prefix ? mol/l

Urine—Amfebutamone;

substance concentrationmole/literM = 239,74 g/molNPU04345U—Amfebutamone; subst.c.= ? prefix ? mol/l

Urine—Amfepramone;

arbitrary concentration(procedure)M = 205,30 g/molOther term(s): DiethylpropionNPU01162U—Amfepramone; arb.c.(proc.) = ?

Urine—Amfepramone;

substance concentrationmicromole/literM = 205,30 g/molOther term(s): DiethylpropionNPU01161U—Amfepramone; subst.c. = ? µmol/l

Urine—Amfetamine;

arbitrary concentration(procedure)M = 135,20 g/molOther term(s): AmphetamineNPU01163U—Amfetamine; arb.c.(proc.) = ?

Urine—Amfetamine;

substance concentrationmicromole/literM = 135,20 g/molOther term(s): AmphetamineNPU01166U—Amfetamine; subst.c. = ? µmol/l


490 H. OLESEN

Urine—Amfetamine+analogue;

arbitrary concentration(procedure)Note: d-Amfetamine; d,l-Amfetamine; d,l-Ephedrine; Isometheptene;Nylidrin;Phentermine; Phenylpropanolamine;TranylcypromineNPU08960U—Amfetamine+analogue; arb.c.(proc.) = ?

Urine—Amfetamine+analogue;

taxon(procedure)Note: Amfetamine; Ephedrine; Fenfluramine;Metamfetamine; 3,4-Methylenedioxyamfetamine; 3,4-Metylenedioxymetamfetamine; 3,4-Metylenedioxymetamfetamine;PseudoephedrineNPU08980U—Amfetamine+analogue; taxon(proc.) = ?

Urine—Amfetaminil;

arbitrary concentration(procedure)M = 250,33 g/molOther term(s): AmphetaminilNPU04913U—Amfetaminil; arb.c.(proc.) = ?

Urine—Amfetaminil;

substance concentrationmicromole/literM = 250,33 g/molOther term(s): AmphetaminilNPU01169U—Amfetaminil; subst.c. = ? µmol/l

Plasma—Amikacin;

arbitrary concentration(procedure)NPU12398P—Amikacin; arb.c.(proc.) = ?

Plasma—Amikacin;

arbitrary substance concentration(procedure)arbitrary unit/literNPU10012P—Amikacin; arb.subst.c.(proc.) = ? arb.unit/l

Plasma—Amikacin;

substance concentrationmole/literNPU10013P—Amikacin; subst.c.= ? prefix ? mol/l

Plasma—Amiloride;

substance concentrationmicromole/literM = 229,65 g/molNPU04773P—Amiloride; subst.c.= ? µmol/l

Urine—Amiloride;

substance concentrationmicromole/literM = 229,65 g/molNPU01172U—Amiloride; subst.c. = ? µmol/l

Urine—Amineptine;

substance concentrationmole/literM = 337,47 g/molNPU04918U—Amineptine; subst.c.= ? prefix ? mol/l

Plasma—Amiodarone;

substance concentration(list; procedure)NPU17592P—Amiodarone; subst.c.(list; proc.)NPU01219 P—Amiodarone; subst.c. = ? µmol/lNPU01220 P—Amiodarone+Desethylamiodarone;subst.c. = ? µmol/lNPU08618 P—Desethylamiodarone; subst.c. = ? µmol/l

Plasma—Amiodarone;

substance concentrationmicromole/literM = 645,32 g/molNPU01219P—Amiodarone; subst.c. = ? µmol/l

Plasma—Amiodarone+Desethylamiodarone;

substance concentrationmicromole/literNPU01220P—Amiodarone+Desethylamiodarone;subst.c. = ? µmol/l

Urine—Amiphenazole;

arbitrary concentration(procedure)M = 191,26 g/molNPU04919U—Amiphenazole; arb.c.(proc.) = ?



Urine—Amiphenazole;

substance concentrationmicromole/literM = 191,26 g/molNPU01223U—Amiphenazole; subst.c. = ? µmol/l

Urine—Amitriptyline;

arbitrary concentration(procedure)M = 277,39 g/molNPU04771U—Amitriptyline; arb.c.(proc.) = ?

Plasma—Amitriptyline;

substance concentrationnanomole/literM = 277,39 g/molNPU01224P—Amitriptyline; subst.c. = ? nmol/l

Urine—Amitriptyline;

substance concentrationnanomole/literM = 277,39 g/molNPU04772U—Amitriptyline; subst.c.= ? nmol/l

Plasma—Amitriptyline+Nortriptyline;

substance concentrationnanomole/literNote: M (amitriptyline) = 277,39 g/mol; M (nortriptyline) = 263,4 g/molNPU03927P—Amitriptyline+Nortriptyline; subst.c. = ?nmol/l

Urine—Amoxapine;

arbitrary concentration(procedure)M = 313,79 g/molNPU01229U—Amoxapine; arb.c.(proc.) = ?

Plasma—Amoxapine;

substance concentrationnanomole/literM = 313,79 g/molNPU01228P—Amoxapine; subst.c. = ? nmol/l

Urine—Amoxapine;

substance concentrationnanomole/literM = 313,79 g/molNPU04508U—Amoxapine; subst.c.= ? nmol/l

Plasma—Amoxapine+metabolite;

substance concentrationnanomole/literNote: 7-Hydroxyamoxapine; 8-HydroxyamoxapineNPU09347P—Amoxapine+metabolite; subst.c. = ? nmol/l

Urine—Amoxicillin;

arbitrary concentration(procedure)M = 365,41 g/molNPU08758U—Amoxicillin; arb.c.(proc.) = ?

Plasma—Amoxicillin;

substance concentrationmicromole/literM = 365,41 g/molNPU08757P—Amoxicillin; subst.c. = ? µmol/l

Urine—Amoxicillin;

substance concentrationmicromole/literM = 365,41 g/molNPU08759U—Amoxicillin; subst.c.= ? µmol/l

Cerebrospinal fluid—Amphotericin B;

substance concentrationmicromole/literNPU12943Csf—Amphotericin B; subst.c. = ? µmol/l

Plasma—Amphotericin B;

substance concentrationmicromole/literNPU12945P—Amphotericin B; subst.c. = ? µmol/l

Secretion(specification)—Amphotericin B;

substance concentrationmicromole/literNPU12944Secr(spec.)—Amphotericin B; subst.c. = ?µmol/l


492 H. OLESEN

Urine—Amphotericin B;

substance concentrationmicromole/literNPU12946U—Amphotericin B; subst.c. = ? µmol/l

Urine—Ampicillin;

arbitrary concentration(procedure)M = 349,41 g/molNPU10275U—Ampicillin; arb.c.(proc.) = ?

Urine—Analgesic drug;

arbitrary concentration(list; procedure)NPU04845U—Analgesic drug; arb.c.(list; proc.)NPU04934 U—Alphaprodine; arb.c.(proc.) = ?NPU04401 U—Anileridine; arb.c.(proc.) = ?NPU04584 U—Buprenorphine; arb.c.(proc.) = ?NPU01710 U—Codeine; arb.c.(proc.) = ?NPU04916 U—Dextromoramide; arb.c.(proc.) = ?NPU01866 U—Dextropropoxyphene; arb.c.(proc.) = ?NPU04450 U—Diamorphine; arb.c.(proc.) = ?NPU04454 U—Dipipanone; arb.c.(proc.) = ?NPU04463 U—Ethoheptazine; arb.c.(proc.) = ?NPU04464 U—Ethylmorphine; arb.c.(proc.) = ?NPU02032 U—Fentanyl; arb.c.(proc.) = ?NPU02408 U—Hydrocodone; arb.c.(proc.) = ?NPU02523 U—Ketobemidone; arb.c.(proc.) = ?NPU04497 U—Levorphanol; arb.c.(proc.) = ?NPU02722 U—Methadone; arb.c.(proc.) = ?NPU02846 U—Morphine(non-complexed); arb.c.(proc.) = ?NPU04536 U—Nalbuphine; arb.c.(proc.) = ?NPU04591 U—Oxycodone; arb.c.(proc.) = ?NPU04596 U—Paracetamol; arb.c.(proc.) = ?NPU03035 U—Pentazocine; arb.c.(proc.) = ?NPU03049 U—Pethidine; arb.c.(proc.) = ?NPU04599 U—Phenazocine; arb.c.(proc.) = ?NPU03384 U—Salicylate; arb.c.(proc.) = ?NPU04549 U—Tramadol; arb.c.(proc.) = ?NPU04647 U—Trimeperidine; arb.c.(proc.) = ?

System(specification)—Analgesic drug;

taxon(procedure)NPU10278Syst(spec.)—Analgesic drug; taxon(proc.) = ?

Urine—Analgesic drug;

taxon(procedure)NPU04479U—Analgesic drug; taxon(proc.) = ?

Urine—Anileridine;

arbitrary concentration(procedure)M = 352,46 g/molNPU04401U—Anileridine; arb.c.(proc.) = ?

Urine—Anileridine;

substance concentrationmicromole/literM = 352,46 g/molNPU01261U—Anileridine; subst.c. = ? µmol/l

System(specification)—Anorectic agent;

taxon(procedure)NPU10279Syst(spec.)—Anorectic agent; taxon(proc.) = ?

Urine—Antazoline;

arbitrary concentration(procedure)M = 265,36 g/molNPU01269U—Antazoline; arb.c.(proc.) = ?

Urine—Antazoline;

substance concentrationmicromole/literM = 265,36 g/molNPU04776U—Antazoline; subst.c. = ? µmol/l

Plasma—Antidepressive drug, tricyclic;

arbitrary concentration(procedure)NPU14177P—Antidepressive drug, tricyclic; arb.c.(proc.) = ?

Urine—Antidepressive drug, tricyclic;

arbitrary concentration(procedure)NPU10006U—Antidepressive drug, tricyclic; arb.c.(proc.) = ?



Urine—Antidepressive drug;

arbitrary concentration(list; procedure)NPU04824U—Antidepressive drug; arb.c.(list; proc.)NPU04771 U—Amitriptyline; arb.c.(proc.) = ?NPU01229 U—Amoxapine; arb.c.(proc.) = ?NPU04784 U—Citalopram; arb.c.(proc.) = ?NPU01617 U—Clomipramine; arb.c.(proc.) = ?NPU01859 U—Desipramine; arb.c.(proc.) = ?NPU04793 U—Dosulepin; arb.c.(proc.) = ?NPU01925 U—Doxepin; arb.c.(proc.) = ?NPU02473 U—Imipramine; arb.c.(proc.) = ?NPU02688 U—Maprotiline; arb.c.(proc.) = ?NPU02816 U—Mianserin; arb.c.(proc.) = ?NPU02924 U—Nortriptyline; arb.c.(proc.) = ?

Plasma—Antidepressive drug;

substance concentration(list)NPU16406P—Antidepressive drug; subst.c.(list)NPU01224 P—Amitriptyline; subst.c. = ? nmol/lNPU01616 P—Clomipramine; subst.c. = ? nmol/lNPU01858 P—Desipramine; subst.c. = ? nmol/lNPU14067 P—Desmethylclomipramine; subst.c. = ?nmol/lNPU02472 P—Imipramine; subst.c. = ? nmol/lNPU02923 P—Nortriptyline; subst.c. = ? nmol/l

System(specification)—Antidepressive drug;

taxon(procedure)NPU10277Syst(spec.)—Antidepressive drug; taxon(proc.) = ?

Urine—Antidepressive drug;

taxon(procedure)NPU04585U—Antidepressive drug; taxon(proc.) = ?

Urine—Atenolol;

arbitrary concentration(procedure)M = 266,34 g/molNPU04579U—Atenolol; arb.c.(proc.) = ?

Urine—Atenolol;

substance concentrationmicromole/literM = 266,34 g/molNPU01336U—Atenolol; subst.c. = ? µmol/l

Plasma—Azithromycin;

substance concentrationmole/literM = 748,99 g/molNPU08773P—Azithromycin; subst.c.= ? prefix ? mol/l

Urine—Barbital;

arbitrary concentration(procedure)M = 184,19 g/molNPU01343U—Barbital; arb.c.(proc.) = ?

Plasma—Barbital;

substance concentrationmicromole/literM = 184,19 g/molNPU10139P—Barbital; subst.c. = ? µmol/l

Urine—Barbital;

substance concentrationmicromole/literM = 184,19 g/molNPU04638U—Barbital; subst.c. = ? µmol/l

Plasma—Barbital;

substance concentrationnanomole/literNPU16400P—Barbital; subst.c. = ? nmol/l

Plasma—Barbiturate(total);

arbitrary concentration(procedure)NPU16395P—Barbiturate(tot.); arb.c.(proc.) = ?

Urine—Barbiturate(total);

arbitrary concentration(procedure)Note: F.ex. Alphenal; Amobarbital; Aprobarbital;Barbital; Butabarbital; Cyclopentobarbital; 5-Ethyl-5-(4-hydroxyphenyl) barbiturate; Pentobarbital;Pentobarbital; Phenobarbital; Secobarbital; Talbutal;ThiopentalNPU08959U—Barbiturate(tot.); arb.c.(proc.) = ?


494 H. OLESEN

Plasma—Barbiturate(total);

substance concentrationmicromole/literNote: F.ex. Alphenal; Amobarbital; Aprobarbital;Barbital; Butabarbital; Cyclopentobarbital; 5-Ethyl-5-(4-hydroxyphenyl) barbiturate; Pentobarbital;Pentobarbital; Phenobarbital; Secobarbital; Talbutal;ThiopentalNPU01344P—Barbiturate(tot.); subst.c. = ? µmol/l

Urine—Barbiturate(total);

substance concentrationmicromole/literNPU04085U—Barbiturate(tot.); subst.c. = ? µmol/l

Urine—Barbiturate;

arbitrary concentration(list; procedure)NPU04826U—Barbiturate; arb.c.(list; proc.)NPU01343 U—Barbital; arb.c.(proc.) = ?NPU04769 U—Butalbital; arb.c.(proc.) = ?NPU03042 U—Pentobarbital; arb.c.(proc.) = ?NPU03063 U—Phenobarbital; arb.c.(proc.) = ?NPU08677 U—Thiopental; arb.c.(proc.) = ?

Plasma—Barbiturate;

substance concentration(list)NPU16396P—Barbiturate; subst.c.(list)NPU16400 P—Barbital; subst.c. = ? nmol/lNPU10139 P—Barbital; subst.c. = ? µmol/lNPU03954 P—Pentobarbital; subst.c. = ? µmol/lNPU16394 P—Pentobarbital; subst.c. = ? nmol/lNPU03062 P—Phenobarbital; subst.c. = ? µmol/lNPU16390 P—Phenobarbital; subst.c. = ? nmol/l

Plasma—Barbiturate;

taxon(procedure)Note: F.ex. Alphenal; Amobarbital; Aprobarbital;Barbital; Butabarbital; Cyclopentobarbital; 5-Ethyl-5-(4-hydroxyphenyl) barbiturate; Pentobarbital;Pentobarbital; Phenobarbital; Secobarbital; Talbutal;ThiopentalNPU01345P—Barbiturate; taxon(proc.) = ?

Urine—Barbiturate;

taxon(procedure)NPU04588U—Barbiturate; taxon(proc.) = ?

Urine—Bemegride;

arbitrary concentration(procedure)M = 155,19 g/molNPU04920U—Bemegride; arb.c.(proc.) = ?

Urine—Bemegride;

substance concentrationmicromole/literM = 155,19 g/molNPU01350U—Bemegride; subst.c. = ? µmol/l

Urine—Bendroflumethiazide;

arbitrary concentration(procedure)M = 421,41 g/molNPU01352U—Bendroflumethiazide; arb.c.(proc.) = ?

Plasma—Bendroflumethiazide;

substance concentrationmicromole/literM = 421,41 g/molNPU08776P—Bendroflumethiazide; subst.c. = ? µmol/l

Urine—Bendroflumethiazide;

substance concentrationmicromole/literM = 421,41 g/molNPU01355U—Bendroflumethiazide; subst.c. = ? µmol/l

Urine—Benzbromarone;

substance concentrationmole/literM = 424,11 g/molNPU04403U—Benzbromarone; subst.c.= ? prefix ? mol/l

Urine—Benzfetamine;

arbitrary concentration(procedure)M = 239,36 g/molNPU04404U—Benzfetamine; arb.c.(proc.) = ?

Urine—Benzfetamine;

substance concentrationmicromole/literM = 239,36 g/molNPU01358U—Benzfetamine; subst.c. = ? µmol/l



Urine—Benzodiazepine;

substance concentrationmicromole/literNPU01360U—Benzodiazepine; subst.c. = ? µmol/l

Plasma—Benzodiazepine;

substance concentrationnanomole/literNPU01359P—Benzodiazepine; subst.c. = ? nmol/l

Urine—Benzodiazepines;

arbitrary concentration(list; procedure)NPU04827U—Benzodiazepines; arb.c.(list; proc.)NPU01402 U—Bromazepam; arb.c.(proc.) = ?NPU01534 U—Chlordiazepoxide; arb.c.(proc.) = ?NPU01880 U—Diazepam; arb.c.(proc.) = ?NPU02062 U—Flunitrazepam; arb.c.(proc.) = ?NPU02614 U—Lorazepam; arb.c.(proc.) = ?NPU02916 U—Nitrazepam; arb.c.(proc.) = ?NPU02975 U—Oxazepam; arb.c.(proc.) = ?


arbitrary concentration(procedure)NPU08958U—Benzodiazepines; arb.c.(proc.) = ?

Plasma—Benzodiazepines;

taxon(procedure)Note: F.ex. Oxazepam; Alprazolam;Benzodiazepine; Bromazepam; Chlordiazepoxide;Clobazam; Clonazepam; Clorazepate; Clotiazepam;Demoxepam; N-Desalkylflurazepam; Diazepam;Flunitrazepam; Flurazepam; Halazepam;a-HydroxyalprazolamNPU09010P—Benzodiazepines; taxon(proc.) = ?

System(specification)—Benzodiazepines;

taxon(procedure)NPU10282Syst(spec.)—Benzodiazepines; taxon(proc.) = ?


taxon(procedure)Note: F.ex. Oxazepam; Alprazolam;Benzodiazepine; Bromazepam; Chlordiazepoxide;Clobazam; Clonazepam; Clorazepate; Clotiazepam;Demoxepam; N-Desalkylflurazepam; Diazepam;Flunitrazepam; Flurazepam; Halazepam;a-HydroxyalprazolamNPU04062U—Benzodiazepines; taxon(proc.) = ?

Urine—Benzoylecgonine;

arbitrary concentration(procedure)Note: Cocaine metaboliteNPU08994U—Benzoylecgonine; arb.c.(proc.) = ?

Urine—Benzoylecgonine;

substance concentrationmicromole/literM = 289,33 g/molNote: Cocaine metaboliteNPU08993U—Benzoylecgonine; subst.c. = ? µmol/l

Urine—Benzquinamide;

arbitrary concentration(procedure)M = 404,49 g/molNPU04338U—Benzquinamide; arb.c.(proc.) = ?

Plasma—Benzquinamide;

substance concentrationmole/literM = 404,49 g/molNPU04340P—Benzquinamide; subst.c.= ? prefix ? mol/l

Urine—Benzquinamide;

substance concentrationmole/literM = 404,49 g/molNPU04339U—Benzquinamide; subst.c.= ? prefix ? mol/l

Urine—Benzthiazide;

substance concentrationmicromole/literM = 431,94 g/molNPU01363U—Benzthiazide; subst.c. = ? µmol/l

Urine—Betaxolol;

arbitrary concentration(procedure)M = 307,43 g/molNPU04405U—Betaxolol; arb.c.(proc.) = ?

Urine—Bevantolol;

arbitrary concentration(procedure)M = 345,44 g/molNPU04406U—Bevantolol; arb.c.(proc.) = ?


496 H. OLESEN

Urine—Biopterin;

substance concentrationmole/literM = 237,22 g/molNPU01373U—Biopterin; subst.c.= ? prefix ? mol/l

Urine—Bisacodyl;

arbitrary concentration(procedure)M = 361,38 g/molNPU01382U—Bisacodyl; arb.c.(proc.) = ?

Urine—Bisacodyl;

substance concentrationmole/literM = 361,38 g/molNPU04779U—Bisacodyl; subst.c.= ? prefix ? mol/l

Urine—Bisoprolol;

arbitrary concentration(procedure)M = 325,45 g/molNPU04407U—Bisoprolol; arb.c.(proc.) = ?

Urine—Bolasterone;

arbitrary concentration(procedure)M = 316,47 g/molNPU04914U—Bolasterone; arb.c.(proc.) = ?

Urine—Bolasterone;

substance concentrationnanomole/literM = 316,47 g/molNPU01396U—Bolasterone; subst.c. = ? nmol/l

Urine—Boldenone;

arbitrary concentration(procedure)M = 286,40 g/molNPU04921U—Boldenone; arb.c.(proc.) = ?

Urine—Boldenone;

substance concentrationnanomole/literM = 286,40 g/molNPU01399U—Boldenone; subst.c. = ? nmol/l

Urine—Bromazepam;

arbitrary concentration(procedure)M = 316,16 g/molNPU01402U—Bromazepam; arb.c.(proc.) = ?

Urine—Bromazepam;

substance concentrationmicromole/literM = 316,16 g/molNPU04648U—Bromazepam; subst.c. = ? µmol/l

Urine—Bromocriptine;

arbitrary concentration(procedure)M = 654,62 g/molNPU04341U—Bromocriptine; arb.c.(proc.) = ?

Plasma—Bromocriptine;

substance concentrationmole/literM = 654,62 g/molNPU04343P—Bromocriptine; subst.c.= ? prefix ? mol/l

Urine—Bromocriptine;

substance concentrationmole/literM = 654,62 g/molNPU04342U—Bromocriptine; subst.c.= ? prefix ? mol/l

Urine—Bromperidol;

arbitrary concentration(procedure)M = 420,33 g/molNPU09038U—Bromperidol; arb.c.(proc.) = ?

Plasma—Bromperidol;

substance concentrationmole/literM = 420,33 g/molNPU09036P—Bromperidol; subst.c.= ? prefix ? mol/l

Urine—Bromperidol;

substance concentrationmole/literM = 420,33 g/molNPU09037U—Bromperidol; subst.c.= ? prefix ? mol/l



Urine—Brotizolam;

arbitrary concentration(procedure)M = 393,70 g/molNPU09059U—Brotizolam; arb.c.(proc.) = ?

Plasma—Brotizolam;

substance concentrationmole/literM = 393,70 g/molNPU09057P—Brotizolam; subst.c.= ? prefix ? mol/l

Urine—Brotizolam;

substance concentrationmole/literM = 393,70 g/molNPU09058U—Brotizolam; subst.c.= ? prefix ? mol/l

Urine—Bumetanide;

arbitrary concentration(procedure)M = 364,42 g/molNPU08604U—Bumetanide; arb.c.(proc.) = ?

Plasma—Bumetanide;

substance concentrationmole/literM = 364,42 g/molNPU01407P—Bumetanide; subst.c.= ? prefix ? mol/l

Urine—Bumetanide;

substance concentrationmicromole/literM = 364,42 g/molNPU01410U—Bumetanide; subst.c. = ? µmol/l

Urine—Bunitrolol;

arbitrary concentration(procedure)M = 248,32 g/molNPU04960U—Bunitrolol; arb.c.(proc.) = ?

Urine—Bunitrolol;

substance concentrationmole/literM = 248,32 g/molNPU04415U—Bunitrolol; subst.c.= ? prefix ? mol/l

Urine—Bunolol;

arbitrary concentration(procedure)M = 291,39 g/molNPU04961U—Bunolol; arb.c.(proc.) = ?

Urine—Bunolol;

substance concentrationmole/literM = 291,39 g/molNPU04416U—Bunolol; subst.c.= ? prefix ? mol/l

Urine—Bupranolol;

arbitrary concentration(procedure)M = 271,79 g/molNPU04962U—Bupranolol; arb.c.(proc.) = ?

Urine—Bupranolol;

substance concentrationmole/literM = 271,79 g/molNPU04419U—Bupranolol; subst.c.= ? prefix ? mol/l

Urine—Buprenorphine;

arbitrary concentration(procedure)M = 467,65 g/molNPU04584U—Buprenorphine; arb.c.(proc.) = ?

Urine—Buprenorphine;

substance concentrationnanomole/literM = 467,65 g/molNPU01413U—Buprenorphine; subst.c. = ? nmol/l

Urine—Buspirone;

arbitrary concentration(procedure)M = 385,51 g/molNPU04347U—Buspirone; arb.c.(proc.) = ?

Urine—Buspirone;

substance concentrationmole/literM = 385,51 g/molNPU04348U—Buspirone; subst.c.= ? prefix ? mol/l


498 H. OLESEN

Plasma—Buspirone;

substance concentrationnanomole/literM = 385,51 g/molNPU04349P—Buspirone; subst.c. = ? nmol/l

Urine—Butalbital;

arbitrary concentration(procedure)M = 224,25 g/molOther term(s): Alisobumal; Allylbarbital; Itobarbital;SandoptalNPU04769U—Butalbital; arb.c.(proc.) = ?

Urine—Butalbital;

substance concentrationmicromole/literM = 224,25 g/molOther term(s): Alisobumal; Allylbarbital; Itobarbital;SandoptalNPU04770U—Butalbital; subst.c. = ? µmol/l

Plasma—Caffeine;

substance concentrationmicromole/literM = 194,19 g/molAuthority: BANNPU04420P—Caffeine; subst.c. = ? µmol/l

Urine—Caffeine;

substance concentrationmicromole/literM = 194,19 g/molAuthority: BANNPU01434U—Caffeine; subst.c. = ? µmol/l

Urine—Cannabinol;

arbitrary concentration(procedure)Other term(s): HashNote: Tetrahydrocannabinols; Cannabinol;CannabidiolNPU08957U—Cannabinol; arb.c.(proc.) = ?

Urine—Cannabinol;

substance concentrationmicromole/literOther term(s): HashNote: Tetrahydrocannabinols; Cannabinol;CannabidiolNPU04622U—Cannabinol; subst.c. = ? µmol/l

Urine—Cannabinol;

substance concentrationnanomole/literOther term(s): HashNote: Tetrahydrocannabinols; Cannabinol;CannabidiolNPU01452U—Cannabinol; subst.c. = ? nmol/l

Urine—Canrenone;

arbitrary concentration(procedure)M = 340,46 g/molNPU04922U—Canrenone; arb.c.(proc.) = ?

Urine—Canrenone;

substance concentrationmicromole/literM = 340,46 g/molNPU01455U—Canrenone; subst.c. = ? µmol/l

Plasma—Carbamazepine epoxide;

substance concentrationmicromole/literNPU08964P—Carbamazepine epoxide; subst.c. = ? µmol/l

Patient—Carbamazepine(administered);

substance rate(oral administration)millimole/dayM = 236,27 g/molNPU10025Pt—Carbamazepine(administered); subst.rate(p.o.)= ? mmol/d

Plasma—Carbamazepine(free);

substance concentrationmicromole/literM = 236,27 g/molNPU08974P—Carbamazepine(free); subst.c. = ? µmol/l



Plasma—Carbamazepine(total);

substance concentrationmicromole/literM = 236,27 g/molNPU01457P—Carbamazepine(tot.); subst.c. = ? µmol/l

Urine—Carbamazepine;

arbitrary concentration(procedure)M = 236,27 g/molNPU04841U—Carbamazepine; arb.c.(proc.) = ?

Urine—Carbamazepine;

substance concentrationmicromole/literM = 236,27 g/molNPU04842U—Carbamazepine; subst.c. = ? µmol/l

Plasma—Carfentanil;

arbitrary concentration(procedure)M = 394,51 g/molNPU04915P—Carfentanil; arb.c.(proc.) = ?

Urine—Carfentanil;

arbitrary concentration(procedure)M = 394,51 g/molNPU04350U—Carfentanil; arb.c.(proc.) = ?

Plasma—Carfentanil;

substance concentrationmole/literM = 394,51 g/molNPU04352P—Carfentanil; subst.c.= ? prefix ? mol/l

Urine—Carfentanil;

substance concentrationmole/literM = 394,51 g/molNPU04351U—Carfentanil; subst.c.= ? prefix ? mol/l

Urine—Carteolol;

arbitrary concentration(procedure)M = 292,38 g/molAuthority: IFCC/C-LDA; *INN88NPU14146U—Carteolol; arb.c.(proc.) = ?

Urine—Carteolol;

substance concentrationmole/literM = 292,38 g/molNPU04923U—Carteolol; subst.c.= ? prefix ? mol/l

Urine—Cathartic drug;

arbitrary concentration(list; procedure)Other term(s): LaxativeNPU08593U—Cathartic drug; arb.c.(list; proc.)NPU01382 U—Bisacodyl; arb.c.(proc.) = ?NPU03064 U—Phenolphthalein; arb.c.(proc.) = ?NPU04820 U—Rhein; arb.c.(proc.) = ?

Urine—Cathine;

arbitrary concentration(procedure)M = 151,21 g/molNPU04421U—Cathine; arb.c.(proc.) = ?

Urine—Cathine;

substance concentrationmicromole/literM = 151,21 g/molNPU01516U—Cathine; subst.c. = ? µmol/l

Cerebrospinal fluid—Chloramphenicol;

substance concentrationmicromole/literNPU12938Csf—Chloramphenicol; subst.c. = ? µmol/l

Plasma—Chloramphenicol;

substance concentrationmicromole/literNPU12934P—Chloramphenicol; subst.c. = ? µmol/l

Secretion(specification)—Chloramphenicol;

substance concentrationmicromole/literNPU12933Secr(spec.)—Chloramphenicol; subst.c. = ? µmol/l

System(specification)—Chloramphenicol;

substance concentrationmicromole/literNPU17513Syst(spec.)—Chloramphenicol; subst.c. = ? µmol/l


500 H. OLESEN

Urine—Chloramphenicol;

substance concentrationmicromole/literNPU12937U—Chloramphenicol; subst.c. = ? µmol/l

Plasma—Chloraniline;

substance concentrationmicromole/literM = 208,98 g/molNPU03854P—Chloraniline; subst.c. = ? µmol/l

Urine—Chlordiazepoxide;

arbitrary concentration(procedure)M = 299,76 g/molNPU01534U—Chlordiazepoxide; arb.c.(proc.) = ?

Urine—Chlordiazepoxide;

substance concentrationmicromole/literM = 299,76 g/molNPU04550U—Chlordiazepoxide; subst.c. = ? µmol/l

Plasma—Chlorhexidine;

substance concentrationmicromole/literM = 505,45 g/molNPU03855P—Chlorhexidine; subst.c. = ? µmol/l

Urine—Chlorhexidine;

substance concentrationmicromole/literM = 505,45 g/molNPU04422U—Chlorhexidine; subst.c. = ? µmol/l

Urine—Chlormerodrin;

substance concentrationmicromole/literM = 367,20 g/molNPU01540U—Chlormerodrin; subst.c. = ? µmol/l

Plasma—Chloroquine;

substance concentrationmole/literM = 319,88 g/molNPU04818P—Chloroquine; subst.c.= ? prefix ? mol/l

Urine—Chlorphentermine;

substance concentrationmicromole/literM = 183,68 g/molNPU01543U—Chlorphentermine; subst.c. = ? µmol/l

Urine—Chlorpromazine;

arbitrary concentration(procedure)M = 318,87 g/molNPU01544U—Chlorpromazine; arb.c.(proc.) = ?

Urine—Chlorpromazine;

substance concentrationmicromole/literM = 318,87 g/molNPU04781U—Chlorpromazine; subst.c.= ? µmol/l

Plasma—Chlorpromazine;

substance concentrationnanomole/literM = 318,87 g/molNPU04822P—Chlorpromazine; subst.c.= ? nmol/l

Urine—Chlorprothixene;

arbitrary concentration(procedure)M = 315,87 g/molNPU01545U—Chlorprothixene; arb.c.(proc.) = ?

Urine—Chlorprothixene;

substance concentrationmicromole/literM = 315,87 g/molNPU04783U—Chlorprothixene; subst.c. = ? µmol/l

Plasma—Chlorprothixene;

substance concentrationnanomole/literM = 315,87 g/molNPU08777P—Chlorprothixene; subst.c. = ? nmol/l

Urine—Chlortalidone;

substance concentrationmicromole/literM = 338,77 g/molNPU01548U—Chlortalidone; subst.c. = ? µmol/l



Urine—Chlortetracycline;

arbitrary substance concentration(procedure)arbitrary unit/literM = 478,89 g/molNPU08821U—Chlortetracycline; arb.subst.c.(proc.) = ?arb.unit/l

Plasma—Chlortetracycline;

substance concentrationmole/literM = 478,89 g/molNPU08820P—Chlortetracycline; subst.c.= ? prefix ? mol/l

Urine—Chlortetracycline;

substance concentrationmole/literM = 478,89 g/molNPU08822U—Chlortetracycline; subst.c.= ? prefix ? mol/l

Blood—Ciclosporin;

substance concentrationmicromole/literM = 1 202,6 g/molNPU01592B—Ciclosporin; subst.c. = ? µmol/l

Blood—Ciclosporin+metabolite;

substance concentrationmicromole/literNPU03990B—Ciclosporin+metabolite; subst.c. = ? µmol/l

Patient—Cimetidine(administered);

substance rate(oral administration)millimole/dayM = 252,34 g/molNPU10036Pt—Cimetidine(administered); subst.rate(p.o.) = ?mmol/d

Urine—Ciprofloxacin;

arbitrary concentration(procedure)NPU10296U—Ciprofloxacin; arb.c.(proc.) = ?

Patient—Citalopram(administered);

substance rate(oral administration)micromole/dayM = 324,40 g/molNPU10037Pt—Citalopram(administered); subst.rate(p.o.) = ?µmol/d

Urine—Citalopram;

arbitrary concentration(procedure)M = 324,40 g/molNPU04784U—Citalopram; arb.c.(proc.) = ?

Urine—Citalopram;

substance concentrationmicromole/literM = 324,40 g/molNPU04785U—Citalopram; subst.c. = ? µmol/l

Plasma—Citalopram;

substance concentrationnanomole/literM = 324,40 g/molNPU04778P—Citalopram; subst.c.= ? nmol/l

Urine—Clemastine;

arbitrary concentration(procedure)M = 343,90 g/molNPU04353U—Clemastine; arb.c.(proc.) = ?

Plasma—Clemastine;

substance concentrationmole/literM = 343,90 g/molNPU04355P—Clemastine; subst.c.= ? prefix ? mol/l

Urine—Clemastine;

substance concentrationmole/literM = 343,90 g/molNPU04354U—Clemastine; subst.c.= ? prefix ? mol/l

Urine—Clenbuterol;

arbitrary concentration(procedure)M = 277,18 g/molNPU04963U—Clenbuterol; arb.c.(proc.) = ?


502 H. OLESEN

Urine—Clenbuterol;

substance concentrationmole/literM = 277,18 g/molNPU04425U—Clenbuterol; subst.c.= ? prefix ? mol/l

Urine—Clindamycin;

arbitrary substance concentration(procedure)arbitrary unit/literM = 424,98 g/molNPU08780U—Clindamycin; arb.subst.c.(proc.) = ? arb.unit/l

Plasma—Clindamycin;

substance concentrationmole/literM = 424,98 g/molNPU08778P—Clindamycin; subst.c.= ? prefix ? mol/l

Urine—Clindamycin;

substance concentrationmole/literM = 424,98 g/molNPU08779U—Clindamycin; subst.c.= ? prefix ? mol/l

Patient—Clobazam(administered);

substance rate(oral administration)micromole/dayM = 300,74 g/molNPU10038Pt—Clobazam(administered); subst.rate(p.o.) = ?µmol/d

Urine—Clobazam;

arbitrary concentration(procedure)M = 300,74 g/molNPU04843U—Clobazam; arb.c.(proc.) = ?

Plasma—Clobazam;

substance concentrationnanomole/literM = 300,74 g/molNPU03932P—Clobazam; subst.c. = ? nmol/l

Urine—Clobazam;

substance concentrationnanomole/literM = 300,74 g/molNPU04844U—Clobazam; subst.c. = ? nmol/l

Urine—Clobenzorex;

arbitrary concentration(procedure)M = 259,78 g/molNPU04428U—Clobenzorex; arb.c.(proc.) = ?

Urine—Clobenzorex;

substance concentrationmicromole/literM = 259,78 g/molNPU01615U—Clobenzorex; subst.c. = ? µmol/l

Urine—Clomethiazole;

arbitrary concentration(procedure)M = 161,66 g/molNPU09063U—Clomethiazole; arb.c.(proc.) = ?

Plasma—Clomethiazole;

substance concentrationmole/literM = 161,66 g/molNPU09061P—Clomethiazole; subst.c.= ? prefix ? mol/l

Urine—Clomethiazole;

substance concentrationmole/literM = 161,66 g/molNPU09062U—Clomethiazole; subst.c.= ? prefix ? mol/l

Patient—Clomipramine(administered);

substance rate(oral administration)micromole/dayM = 314,87 g/molNPU10039Pt—Clomipramine(administered); subst.rate(p.o.) =? µmol/d

Urine—Clomipramine;

arbitrary concentration(procedure)M = 314,87 g/molNPU01617U—Clomipramine; arb.c.(proc.) = ?



Plasma—Clomipramine;

substance concentrationnanomole/literM = 314,87 g/molNPU01616P—Clomipramine; subst.c. = ? nmol/l

Urine—Clomipramine;

substance concentrationnanomole/literM = 314,87 g/molNPU04787U—Clomipramine; subst.c. = ? nmol/l

Plasma—Clomipramine+Desmethylclomipramine;

substance concentrationnanomole/literNote: M (clomipramine) = 314,87 g/molNPU03933P—Clomipramine+Desmethylclomipramine; subst.c.= ? nmol/l

Patient—Clonazepam(administered);

substance rate(oral administration)micromole/dayM = 315,72 g/molNPU10040Pt—Clonazepam(administered); subst.rate(p.o.) = ?µmol/d

Urine—Clonazepam;

arbitrary concentration(procedure)M = 315,72 g/molNPU04847U—Clonazepam; arb.c.(proc.) = ?

Plasma—Clonazepam;

substance concentrationnanomole/literM = 315,72 g/molNPU01618P—Clonazepam; subst.c. = ? nmol/l

Urine—Clonazepam;

substance concentrationnanomole/literM = 315,72 g/molNPU04848U—Clonazepam; subst.c. = ? nmol/l

Urine—Clopamide;

substance concentrationmole/literM = 345,86 g/molNPU04431U—Clopamide; subst.c.= ? prefix ? mol/l

Urine—Clopenthixol;

arbitrary concentration(procedure)M = 401,0 g/molNPU04088U—Clopenthixol; arb.c.(proc.) = ?

Urine—Clopenthixol;

substance concentrationmole/literM = 401,0 g/molNPU04087U—Clopenthixol; subst.c.= ? prefix ? mol/l

Plasma—Clopenthixol;

substance concentrationnanomole/literM = 401,0 g/molNPU04086P—Clopenthixol; subst.c. = ? nmol/l

Urine—Clorazepate;

arbitrary concentration(procedure)Note: M (anion) = 313,73 g/molNPU01911U—Clorazepate; arb.c.(proc.) = ?

Urine—Clorazepate;

substance concentrationmicromole/literNote: M (anion) = 313,73 g/molNPU04849U—Clorazepate; subst.c. = ? µmol/l

Urine—Clorprenaline;

arbitrary concentration(procedure)M = 213,71 g/molNPU04434U—Clorprenaline; arb.c.(proc.) = ?

Urine—Clorprenaline;

substance concentrationmicromole/literM = 213,71 g/molNPU01622U—Clorprenaline; subst.c. = ? µmol/l


504 H. OLESEN

Urine—Clostebol;

arbitrary concentration(procedure)M = 322,87 g/molNPU04437U—Clostebol; arb.c.(proc.) = ?

Urine—Clostebol;

substance concentrationmicromole/literM = 322,87 g/molNPU01625U—Clostebol; subst.c. = ? µmol/l

Urine—Clozapine;

arbitrary concentration(procedure)M = 326,83 g/molNPU09039U—Clozapine; arb.c.(proc.)= ?

Plasma—Clozapine;

substance concentrationnanomole/literM = 326,83 g/molNPU04114P—Clozapine; subst.c. = ? nmol/l

Urine—Clozapine;

substance concentrationnanomole/literM = 326,83 g/molNPU04116U—Clozapine; subst.c. = ? nmol/l

Urine—Cocaine;

arbitrary concentration(procedure)M = 303,36 g/molAuthority: BANNPU01706U—Cocaine; arb.c.(proc.) = ?

Urine—Cocaine+metabolite;

arbitrary concentration(procedure)Note: Cocaine; Benzoylecgonine; Ecgonine;Ecgonine methylesterNPU08955U—Cocaine+metabolite; arb.c.(proc.) = ?

Urine—Cocaine+metabolite;

substance concentrationmicromole/literNote: Cocaine; Benzoylecgonine; Ecgonine;Ecgonine methylesterNPU01709U—Cocaine+metabolite; subst.c. = ? µmol/l

Urine—Codeine;

arbitrary concentration(procedure)M = 299,37 g/molAuthority: BANNPU01710U—Codeine; arb.c.(proc.) = ?

Urine—Codeine;

substance concentrationmicromole/literM = 299,37 g/molAuthority: BANNPU01713U—Codeine; subst.c. = ? µmol/l

Plasma—Codeine;

substance concentrationnanomole/literM = 299,37 g/molAuthority: BANNPU08781P—Codeine; subst.c. = ? nmol/l

Urine—Colchicine;

arbitrary concentration(procedure)M = 399,44 g/molNPU04356U—Colchicine; arb.c.(proc.) = ?

Plasma—Colchicine;

substance concentrationmole/literM = 399,44 g/molNPU04358P—Colchicine; subst.c.= ? prefix ? mol/l

Urine—Colchicine;

substance concentrationmole/literM = 399,44 g/molNPU04357U—Colchicine; subst.c.= ? prefix ? mol/l

Plasma—Cotinine;

substance concentrationnanomole/literM = 176,21 g/molNPU10041P—Cotinine; subst.c. = ? nmol/l



Urine—Cotinine;

substance concentrationnanomole/literM = 176,21 g/molNPU10042U—Cotinine; subst.c. = ? nmol/l

Urine—Cropropamide;

arbitrary concentration(procedure)M = 240,35 g/molNPU04440U—Cropropamide; arb.c.(proc.) = ?

Urine—Cropropamide;

substance concentrationmicromole/literM = 240,35 g/molNPU01812U—Cropropamide; subst.c. = ? µmol/l

Urine—Crotetamide;

arbitrary concentration(procedure)M = 226,32 g/molNPU04443U—Crotetamide; arb.c.(proc.) = ?

Urine—Crotetamide;

substance concentrationmicromole/literM = 226,32 g/molOther term(s): CrotethamideNPU01815U—Crotetamide; subst.c. = ? µmol/l

Urine—Danazol;

substance concentrationmole/literM = 337,47 g/molNPU04446U—Danazol; subst.c.= ? prefix ? mol/l

Urine—Dantrolene;

arbitrary concentration(procedure)M = 314,26 g/molNPU04364U—Dantrolene; arb.c.(proc.) = ?

Plasma—Dantrolene;

substance concentrationmole/literM = 314,26 g/molNPU04366P—Dantrolene; subst.c.= ? prefix ? mol/l

Urine—Dantrolene;

substance concentrationmole/literM = 314,26 g/molNPU04365U—Dantrolene; subst.c.= ? prefix ? mol/l

Urine—Dantron;

substance concentrationmole/literM = 240,21 g/molNPU01848U—Dantron; subst.c.= ? prefix ? mol/l

Urine—Debrisoquine;

arbitrary substance concentration(procedure)arbitrary unit/literM = 175,23 g/molNPU08783U—Debrisoquine; arb.subst.c.(proc.) = ? arb.unit/l

Urine—Debrisoquine;

substance concentrationmole/literM = 175,23 g/molNPU08782U—Debrisoquine; subst.c.= ? prefix ? mol/l

Plasma—Deferoxamine(Fe);

substance concentrationmicromole/literM = 560,71 g/molNPU10137P—Deferoxamine(Fe); subst.c. = ? µmol/l

Plasma—Desethylamiodarone;

substance concentrationmicromole/literM = 617,27 g/molNPU08618P—Desethylamiodarone; subst.c. = ? µmol/l

Urine—Desipramine;

arbitrary concentration(procedure)M = 266,37 g/molNPU01859U—Desipramine; arb.c.(proc.) = ?

Plasma—Desipramine;

substance concentrationnanomole/literM = 266,37 g/molNPU01858P—Desipramine; subst.c. = ? nmol/l


506 H. OLESEN

Urine—Desipramine;

substance concentrationnanomole/literM = 266,37 g/molNPU04789U—Desipramine; subst.c. = ? nmol/l

Plasma—Desmethylclomipramine;

substance concentrationnanomole/literNote: M (clomipramine) = 314,87 g/molNPU14067P—Desmethylclomipramine; subst.c. = ? nmol/l

Plasma—Desmethyldoxepin;

substance concentrationnanomole/literNPU10304P—Desmethyldoxepin; subst.c. = ? nmol/l

Urine—Dextromethorphan;

arbitrary concentration(procedure)M = 271,41 g/molNPU04580U—Dextromethorphan; arb.c.(proc.) = ?

Plasma—Dextromethorphan;

substance concentrationmole/literM = 271,41 g/molNPU04370P—Dextromethorphan; subst.c.= ? prefix ? mol/l

Urine—Dextromethorphan;

substance concentrationmole/literM = 271,41 g/molNPU04581U—Dextromethorphan; subst.c.= ? prefix ? mol/l

Urine—Dextromoramide;

arbitrary concentration(procedure)M = 392,54 g/molNPU04916U—Dextromoramide; arb.c.(proc.) = ?

Urine—Dextromoramide;

substance concentrationmicromole/literM = 392,54 g/molNPU01862U—Dextromoramide; subst.c. = ? µmol/l

Plasma—Dextropropoxyphene;

arbitrary concentration(procedure)M = 339,48 g/molOther term(s): PropoxypheneNPU04917P—Dextropropoxyphene; arb.c.(proc.) = ?

System(specification)—Dextropropoxyphene;

arbitrary concentration(procedure)M = 339,48 g/molOther term(s): PropoxypheneNPU10305Syst(spec.)—Dextropropoxyphene; arb.c.(proc.) = ?

Urine—Dextropropoxyphene;

arbitrary concentration(procedure)M = 339,48 g/molOther term(s): PropoxypheneNPU01866U—Dextropropoxyphene; arb.c.(proc.) = ?

Plasma—Dextropropoxyphene;

substance concentrationmicromole/literM = 339,48 g/molOther term(s): PropoxypheneNPU01863P—Dextropropoxyphene; subst.c. = ? µmol/l

Urine—Dextropropoxyphene;

substance concentrationmicromole/literM = 339,48 g/molOther term(s): PropoxypheneNPU01867U—Dextropropoxyphene; subst.c. = ? µmol/l

Patient(Urine)—Dextropropoxyphene;

substance ratemicromole/dayM = 339,48 g/molNPU10138Pt(U)—Dextropropoxyphene; subst.rate = ? µmol/d

Urine—Diamorphine;

arbitrary concentration(procedure)M = 369,42 g/molOther term(s): HeroinAuthority: BANNPU04450U—Diamorphine; arb.c.(proc.) = ?



Urine—Diamorphine;

substance concentrationmicromole/literM = 369,42 g/molOther term(s): HeroinAuthority: BANNPU01878U—Diamorphine; subst.c. = ? µmol/l

Urine—Diazepam;

arbitrary concentration(procedure)M = 284,74 g/molNPU01880U—Diazepam; arb.c.(proc.) = ?

Plasma—Diazepam;

substance concentrationmicromole/literM = 284,74 g/molNPU01879P—Diazepam; subst.c. = ? µmol/l

Urine—Diazepam;

substance concentrationmicromole/literM = 284,74 g/molNPU04665U—Diazepam; subst.c. = ? µmol/l

Urine—Diclofenac;

arbitrary concentration(procedure)M = 296,16 g/molNPU04371U—Diclofenac; arb.c.(proc.) = ?

Plasma—Diclofenac;

substance concentrationmole/literM = 296,16 g/molNPU04373P—Diclofenac; subst.c.= ? prefix ? mol/l

Urine—Diclofenac;

substance concentrationmole/literM = 296,16 g/molNPU04372U—Diclofenac; subst.c.= ? prefix ? mol/l

Urine—Diclophenamide;

arbitrary concentration(procedure)M = 305,16 g/molNPU04451U—Diclophenamide; arb.c.(proc.) = ?

Urine—Diclophenamide;

substance concentrationmicromole/literM = 305,16 g/molOther term(s): DichlorphenamideNPU01885U—Diclophenamide; subst.c. = ? µmol/l

Plasma—Dicloxacillin;

substance concentrationmole/literM = 470,33 g/molNPU08784P—Dicloxacillin; subst.c.= ? prefix ? mol/l

Plasma—Digitoxin;

substance concentrationnanomole/literM = 764,92 g/molNPU04786P—Digitoxin; subst.c.= ? nmol/l

Plasma—Digoxin;

substance concentrationnanomole/literM = 780,92 g/molNPU01886P—Digoxin; subst.c. = ? nmol/l

Urine—Dihydrocodeine;

arbitrary concentration(procedure)M = 301,37 g/molNPU04452U—Dihydrocodeine; arb.c.(proc.) = ?

Urine—Dihydrocodeine;

substance concentrationmicromole/literM = 301,37 g/molNPU01889U—Dihydrocodeine; subst.c. = ? µmol/l


508 H. OLESEN

Urine—Diltiazem;

arbitrary concentration(procedure)M = 414,52 g/molNPU04374U—Diltiazem; arb.c.(proc.) = ?

Plasma—Diltiazem;

substance concentrationmole/literM = 414,52 g/molNPU04376P—Diltiazem; subst.c.= ? prefix ? mol/l

Urine—Diltiazem;

substance concentrationmole/literM = 414,52 g/molNPU04375U—Diltiazem; subst.c.= ? prefix ? mol/l

Urine—Dimetamfetamine;

arbitrary concentration(procedure)M = 163,26 g/molOther term(s): DimethylamfetamineNPU04453U—Dimetamfetamine; arb.c.(proc.) = ?

Urine—Dimetamfetamine;

substance concentrationmicromole/literM = 163,26 g/molOther term(s): DimethylamfetamineNPU01902U—Dimetamfetamine; subst.c. = ? µmol/l

Plasma—Dimethadione;

substance concentrationmillimole/literM = 129,11 g/molNPU10140P—Dimethadione; subst.c. = ? mmol/l

Plasma—Dimethyltryptamine;

substance concentrationmicromole/literM = 188,27 g/molNPU01903P—Dimethyltryptamine; subst.c. = ? µmol/l

Urine—Dimethyltryptamine;

substance concentrationmicromole/literM = 188,27 g/molNPU01904U—Dimethyltryptamine; subst.c. = ? µmol/l

Urine—Diphenhydramine;

arbitrary concentration(procedure)M = 255,35 g/molNPU01906U—Diphenhydramine; arb.c.(proc.) = ?

Urine—Diphenhydramine;

substance concentrationmicromole/literM = 255,35 g/molNPU04791U—Diphenhydramine; subst.c. = ? µmol/l

Urine—Diphenoxylic acid;

arbitrary concentration(procedure)M = 452,57 g/molNPU04670U—Diphenoxylic acid; arb.c.(proc.) = ?

Plasma—Diphenoxylic acid;

substance concentrationmole/literM = 452,57 g/molNPU04377P—Diphenoxylic acid; subst.c.= ? prefix ? mol/l

Urine—Diphenoxylic acid;

substance concentrationmole/literM = 452,57 g/molNPU04458U—Diphenoxylic acid; subst.c.= ? prefix ? mol/l

Urine—Dipipanone;

arbitrary concentration(procedure)M = 349,52 g/molNPU04454U—Dipipanone; arb.c.(proc.) = ?

Urine—Dipipanone;

substance concentrationmicromole/literM = 349,52 g/molNPU01910U—Dipipanone; subst.c. = ? µmol/l



Plasma—Disopyramide;

substance concentrationmicromole/literM = 339,47 g/molNPU01912P—Disopyramide; subst.c. = ? µmol/l

Urine—Diuretic drug;

arbitrary concentration(list; procedure)NPU04792U—Diuretic drug; arb.c.(list; proc.)NPU01352 U—Bendroflumethiazide; arb.c.(proc.) = ?NPU08604 U—Bumetanide; arb.c.(proc.) = ?NPU02138 U—Furosemide; arb.c.(proc.) = ?NPU04597 U—Hydroflumethiazide; arb.c.(proc.) = ?

Urine—Diuretic drug;

taxon(procedure)NPU04578U—Diuretic drug; taxon(proc.) = ?

Urine—Dopamine;

substance concentrationnanomole/literM = 153,18 g/molNPU14174U—Dopamine; subst.c. = ? nmol/l

Patient(Urine)—Dopamine;

substance ratenanomole/dayM = 153,18 g/molNPU14175Pt(U)—Dopamine; subst.rate = ? nmol/d

Urine—Dosulepin;

arbitrary concentration(procedure)M = 295,45 g/molOther term(s): DothiepinNPU04793U—Dosulepin; arb.c.(proc.) = ?

Plasma—Dosulepin;

substance concentrationmicromole/literM = 295,45 g/molOther term(s): DothiepinNPU08785P—Dosulepin; subst.c. = ? µmol/l

Urine—Dosulepin;

substance concentrationmicromole/literM = 295,45 g/molOther term(s): DothiepinNPU04794U—Dosulepin; subst.c. = ? µmol/l

Plasma—Dosulepin+Northiaden;

substance concentrationmicromole/literOther term(s): Dothiepin for DosulepinNPU10321P—Dosulepin+Northiaden; subst.c. = ? µmol/l

Plasma—Doxazosin;

substance concentrationmole/literM = 451,48 g/molNPU08786P—Doxazosin; subst.c.= ? prefix ? mol/l

Urine—Doxepin;

arbitrary concentration(procedure)M = 279,38 g/molNPU01925U—Doxepin; arb.c.(proc.) = ?

Plasma—Doxepin;

substance concentrationnanomole/literM = 279,38 g/molNPU01924P—Doxepin; subst.c. = ? nmol/l

Urine—Doxepin;

substance concentrationnanomole/literM = 279,38 g/molNPU04796U—Doxepin; subst.c. = ? nmol/l

Plasma—Doxepin+Desmethyldoxepin;

substance concentrationnanomole/literNote: M (doxepin) = 279,38 g/molNPU03934P—Doxepin+Desmethyldoxepin; subst.c. = ? nmol/l


510 H. OLESEN

Plasma—Doxycycline;

substance concentrationmole/literM = 462,46 g/molNPU08787P—Doxycycline; subst.c.= ? prefix ? mol/l

Urine—Doxylamine;

arbitrary concentration(procedure)M = 270,38 g/molNPU04378U—Doxylamine; arb.c.(proc.) = ?

Plasma—Doxylamine;

substance concentrationmole/literM = 270,38 g/molNPU04380P—Doxylamine; subst.c.= ? prefix ? mol/l

Urine—Doxylamine;

substance concentrationmole/literM = 270,38 g/molNPU04379U—Doxylamine; subst.c.= ? prefix ? mol/l

Urine—Droperidol;

arbitrary concentration(procedure)M = 379,44 g/molNPU09042U—Droperidol; arb.c.(proc.) = ?

Plasma—Droperidol;

substance concentrationmole/literM = 379,44 g/molNPU09040P—Droperidol; subst.c.= ? prefix ? mol/l

Urine—Droperidol;

substance concentrationmole/literM = 379,44 g/molNPU09041U—Droperidol; subst.c.= ? prefix ? mol/l

Urine—Drostanolone;

arbitrary concentration(procedure)M = 304,46 g/molNPU04455U—Drostanolone; arb.c.(proc.) = ?

Urine—Drostanolone;

substance concentrationmole/literM = 304,46 g/molNPU04456U—Drostanolone; subst.c.= ? prefix ? mol/l

Urine—Enalapril;

arbitrary concentration(procedure)M = 376,45 g/molNPU04381U—Enalapril; arb.c.(proc.) = ?

Plasma—Enalapril;

substance concentrationmole/literM = 376,45 g/molNPU04383P—Enalapril; subst.c.= ? prefix ? mol/l

Urine—Enalapril;

substance concentrationmole/literM = 376,45 g/molNPU04382U—Enalapril; subst.c.= ? prefix ? mol/l

Plasma—Endothelin;

substance concentrationpicomole/literOther term(s): Endothelin-1; ET-1Note: M: approx. 2 500NPU10141P—Endothelin; subst.c. = ? pmol/l

Plasma—Enrofloxacin;

substance concentrationmole/literM = 359,40 g/molNPU08788P—Enrofloxacin; subst.c.= ? prefix ? mol/l

Urine—Ephedrine;

arbitrary concentration(procedure)M = 165,23 g/molAuthority: BANNPU04457U—Ephedrine; arb.c.(proc.) = ?



Urine—Ephedrine;

substance concentrationmicromole/literM = 165,23 g/molAuthority: BANNPU01938U—Ephedrine; subst.c. = ? µmol/l

Plasma—Erythromycin;

substance concentrationmole/literNPU14351P—Erythromycin; subst.c.= ? prefix ? mol/l

Urine—Estazolam;

arbitrary concentration(procedure)M = 294,74 g/molNPU01971U—Estazolam; arb.c.(proc.) = ?

Urine—Estazolam;

substance concentrationmicromole/literM = 294,74 g/molNPU01686U—Estazolam; subst.c. = ? µmol/l

Plasma—Estazolam;

substance concentrationnanomole/literM = 294,74 g/molNPU09060P—Estazolam; subst.c. = ? nmol/l

Urine—Etacrynate;

arbitrary concentration(procedure)Note: M (anion) = 302,14 g/molNPU04461U—Etacrynate; arb.c.(proc.) = ?

Urine—Etacrynate;

substance concentrationmicromole/literNote: M (anion) = 302,14 g/molNPU01985U—Etacrynate; subst.c. = ? µmol/l

Urine—Etafedrine;

substance concentrationmicromole/literM = 193,28 g/molNPU01988U—Etafedrine; subst.c. = ? µmol/l

Urine—Etamivan;

arbitrary concentration(procedure)M = 223,27 g/molNPU04462U—Etamivan; arb.c.(proc.) = ?

Urine—Etamivan;

substance concentrationmicromole/literM = 223,27 g/molNPU01991U—Etamivan; subst.c. = ? µmol/l

Urine—Ethambutol;

arbitrary concentration(procedure)M = 204,31 g/molNPU04384U—Ethambutol; arb.c.(proc.) = ?

Plasma—Ethambutol;

substance concentrationmicromole/literM = 204,31 g/molNPU04386P—Ethambutol; subst.c.= ? µmol/l

Urine—Ethambutol;

substance concentrationmicromole/literM = 204,31 g/molNPU04385U—Ethambutol; subst.c. = ? µmol/l

Urine—Ethanol;

arbitrary concentration(procedure)M = 46,07 g/molNPU04592U—Ethanol; arb.c.(proc.) = ?

Plasma—Ethanol;

substance concentrationmillimole/literM = 46,07 g/molOther term(s): Alcohol; Ethyl alcoholNPU01992P—Ethanol; subst.c. = ? mmol/l

Urine—Ethanol;

substance concentrationmillimole/literM = 46,07 g/molOther term(s): Alcohol; Ethyl alcoholNPU01993U—Ethanol; subst.c. = ? mmol/l


512 H. OLESEN

Plasma—Ethanolamine;

substance concentrationmicromole/literM = 61,08 g/molNPU01994P—Ethanolamine; subst.c. = ? µmol/l

Urine—Ethanolamine;

substance concentrationmicromole/literM = 61,08 g/molNPU01995U—Ethanolamine; subst.c. = ? µmol/l

Urine—Ethoheptazine;

arbitrary concentration(procedure)M = 261,35 g/molNPU04463U—Ethoheptazine; arb.c.(proc.) = ?

Urine—Ethoheptazine;

substance concentrationmicromole/literM = 261,35 g/molNPU01998U—Ethoheptazine; subst.c. = ? µmol/l

Plasma—Ethosuximide;

substance concentrationmicromole/literM = 141,17 g/molNPU01999P—Ethosuximide; subst.c. = ? µmol/l

Plasma—Ethotoin;

substance concentrationmicromole/literM = 204,22 g/molNPU10147P—Ethotoin; subst.c. = ? µmol/l

Plasma—Ethylenediamine;

substance concentrationmole/literM = 60,10 g/molNPU08789P—Ethylenediamine; subst.c.= ? prefix ? mol/l

Urine—Ethylmorphine;

arbitrary concentration(procedure)M = 313,38 g/molAuthority: BANNPU04464U—Ethylmorphine; arb.c.(proc.) = ?

Urine—Ethylmorphine;

substance concentrationmicromole/literM = 313,38 g/molAuthority: BANNPU02003U—Ethylmorphine; subst.c. = ? µmol/l

Urine—N-

Ethylnicotinamide;substance concentrationmole/literM = 150,18 g/molNPU02004U—N-Ethylnicotinamide; subst.c.= ? prefix ? mol/l

Urine—Etidocaine;

arbitrary concentration(procedure)M = 276,42 g/molNPU04387U—Etidocaine; arb.c.(proc.) = ?

Plasma—Etidocaine;

substance concentrationmole/literM = 276,42 g/molNPU04389P—Etidocaine; subst.c.= ? prefix ? mol/l

Urine—Etidocaine;

substance concentrationmole/literM = 276,42 g/molNPU04388U—Etidocaine; subst.c.= ? prefix ? mol/l

Urine—Etilamfetamine;

arbitrary concentration(procedure)M = 163,26 g/molOther term(s): EthylamfetamineNPU04467U—Etilamfetamine; arb.c.(proc.) = ?

Urine—Etilamfetamine;

substance concentrationmicromole/literM = 163,25 g/molOther term(s): EthylamfetamineNPU02007U—Etilamfetamine; subst.c. = ? µmol/l



Urine—Etilefrine;

arbitrary concentration(procedure)M = 181,23 g/molNPU04471U—Etilefrine; arb.c.(proc.) = ?

Urine—Etilefrine;

substance concentrationmicromole/literM = 181,23 g/molNPU02010U—Etilefrine; subst.c. = ? µmol/l

Urine—Famotidine;

arbitrary concentration(procedure)M = 337,45 g/molNPU04390U—Famotidine; arb.c.(proc.) = ?

Plasma—Famotidine;

substance concentrationmole/literM = 337,45 g/molNPU04392P—Famotidine; subst.c.= ? prefix ? mol/l

Urine—Famotidine;

substance concentrationmole/literM = 337,45 g/molNPU04391U—Famotidine; subst.c.= ? prefix ? mol/l

Patient—Felbamate(administered);

substance rate(oral administration)millimole/dayNPU10149Pt—Felbamate(administered); subst.rate(p.o.) = ?mmol/d

Plasma—Felbamate;

substance concentrationmicromole/literM = 238,24 g/molNPU10148P—Felbamate; subst.c. = ? µmol/l

Urine—Fencamfamin;

arbitrary concentration(procedure)M = 215,34 g/molNPU04472U—Fencamfamin; arb.c.(proc.) = ?

Urine—Fencamfamin;

substance concentrationmicromole/literM = 215,34 g/molNPU02024U—Fencamfamin; subst.c. = ? µmol/l

Urine—Fenetylline;

arbitrary concentration(procedure)M = 341,40 g/molNPU04474U—Fenetylline; arb.c.(proc.) = ?

Urine—Fenetylline;

substance concentrationmicromole/literM = 341,41 g/molNPU02027U—Fenetylline; subst.c. = ? µmol/l

Urine—Fenfluramine;

arbitrary concentration(procedure)M = 231,27 g/molNPU02028U—Fenfluramine; arb.c.(proc.) = ?

Urine—Fenfluramine;

substance concentrationmicromole/literM = 231,27 g/molNPU04475U—Fenfluramine; subst.c. = ? µmol/l

Urine—Fenoterol;

substance concentrationmicromole/literM = 303,37 g/molNPU04476U—Fenoterol; subst.c. = ? µmol/l

Urine—Fenproporex;

substance concentrationmicromole/literM = 188,27 g/molNPU02031U—Fenproporex; subst.c. = ? µmol/l

Plasma—Fentanyl;

arbitrary concentration(procedure)M = 336,46 g/molNPU04485P—Fentanyl; arb.c.(proc.) = ?


514 H. OLESEN

Urine—Fentanyl;

arbitrary concentration(procedure)M = 336,46 g/molNPU02032U—Fentanyl; arb.c.(proc.) = ?

Plasma—Fentanyl;

substance concentrationnanomole/literM = 336,46 g/molNPU08918P—Fentanyl; subst.c. = ? nmol/l

Urine—Fentanyl;

substance concentrationnanomole/literM = 336,46 g/molNPU04686U—Fentanyl; subst.c. = ? nmol/l

Plasma—Flecainide;

substance concentrationmicromole/literM = 414,35 g/molNPU02059P—Flecainide; subst.c. = ? µmol/l

Plasma—Flucytosine;

substance concentrationmole/literM = 129,09 g/molNPU04788P—Flucytosine; subst.c.= ? prefix ? mol/l

Cerebrospinal fluid—Flucytosine;

substance concentrationmicromole/literNPU12950Csf—Flucytosine; subst.c. = ? µmol/l

Plasma—Flucytosine;

substance concentrationmicromole/literNPU12947P—Flucytosine; subst.c. = ? µmol/l

Secretion(specification)—Flucytosine;

substance concentrationmicromole/literNPU12949Secr(spec.)—Flucytosine; subst.c. = ? µmol/l

System(specification)—Flucytosine;

substance concentrationmicromole/literNPU17518Syst(spec.)—Flucytosine; subst.c. = ? µmol/l

Urine—Flucytosine;

substance concentrationmicromole/literNPU12948U—Flucytosine; subst.c. = ? µmol/l

Plasma—Flumazenil;

substance concentrationmicromole/literM = 303,29 g/molNPU10151P—Flumazenil; subst.c. = ? µmol/l

Urine—Flunitrazepam;

arbitrary concentration(procedure)M = 313,29 g/molNPU02062U—Flunitrazepam; arb.c.(proc.) = ?

Urine—Flunitrazepam;

substance concentrationmicromole/literM = 313,29 g/molNPU04685U—Flunitrazepam; subst.c. = ? µmol/l

Plasma—Flunitrazepam;

substance concentrationnanomole/literM = 313,29 g/molNPU04795P—Flunitrazepam; subst.c.= ? nmol/l

Patient—Fluoxetine(administered);

substance rate(oral administration)micromole/dayM = 309,33 g/molNPU10257Pt—Fluoxetine(administered); subst.rate(p.o.)= ? µmol/d

Urine—Fluoxetine;

arbitrary concentration(procedure)M = 309,33 g/molNPU09072U—Fluoxetine; arb.c.(proc.) = ?



Plasma—Fluoxetine;

substance concentrationnanomole/literM = 309,33 g/molNPU08790P—Fluoxetine; subst.c. = ? nmol/l

Urine—Fluoxetine;

substance concentrationnanomole/literM = 309,33 g/molNPU09071U—Fluoxetine; subst.c. = ? nmol/l

Urine—Fluoxymesterone;

arbitrary concentration(procedure)M = 336,45 g/molNPU04687U—Fluoxymesterone; arb.c.(proc.) = ?

Plasma—Fluoxymesterone;

substance concentrationnanomole/literM = 336,45 g/molNPU04393P—Fluoxymesterone; subst.c.= ? nmol/l

Urine—Fluoxymesterone;

substance concentrationnanomole/literM = 336,45 g/molNPU02066U—Fluoxymesterone; subst.c. = ? nmol/l

Urine—Flupentixol;

arbitrary concentration(procedure)M = 434,54 g/molNPU02067U—Flupentixol; arb.c.(proc.) = ?

Plasma—Flupentixol;

substance concentrationnanomole/literM = 434,54 g/molNPU04797P—Flupentixol; subst.c.= ? nmol/l

Urine—Flupentixol;

substance concentrationnanomole/literM = 434,54 g/molNPU03740U—Flupentixol; subst.c.= ? nmol/l

Urine—Fluphenazine;

arbitrary concentration(procedure)M = 437,53 g/molNPU02068U—Fluphenazine; arb.c.(proc.) = ?

Plasma—Fluphenazine;

substance concentrationnanomole/literM = 437,53 g/molNPU04790P—Fluphenazine; subst.c.= ? nmol/l

Urine—Fluphenazine;

substance concentrationnanomole/literM = 437,53 g/molNPU09035U—Fluphenazine; subst.c.= ? nmol/l

Urine—Flurazepam;

arbitrary concentration(procedure)M = 387,89 g/molNPU02069U—Flurazepam; arb.c.(proc.) = ?

Urine—Flurazepam;

substance concentrationmicromole/literM = 387,89 g/molNPU01587U—Flurazepam; subst.c. = ? µmol/l

Patient—Fluvoxamine(administered);

substance rate(oral administration)micromole/dayM = 318,34 g/molNPU10310Pt—Fluvoxamine(administered); subst.rate(p.o.) = ?µmol/d

Urine—Fluvoxamine;

arbitrary concentration(procedure)M = 318,34 g/molNPU09073U—Fluvoxamine; arb.c.(proc.)= ?

Plasma—Fluvoxamine;

substance concentrationnanomole/literM = 318,34 g/molNPU04117P—Fluvoxamine; subst.c. = ? nmol/l


516 H. OLESEN

Urine—Fluvoxamine;

substance concentrationnanomole/literM = 318,34 g/molNPU04118U—Fluvoxamine; subst.c.= ? nmol/l

Urine—Formebolone;

arbitrary concentration(procedure)M = 344,45 g/molNPU04489U—Formebolone; arb.c.(proc.) = ?

Urine—Formebolone;

substance concentrationmole/literM = 344,45 g/molNPU04935U—Formebolone; subst.c.= ? prefix ? mol/l

Urine—Fucidin;

arbitrary substance concentration(procedure)arbitrary unit/literNPU10154U—Fucidin; arb.subst.c.(proc.) = ? arb.unit/l

Plasma—Fucidin;

substance concentrationmole/literNPU10311P—Fucidin; subst.c.= ? prefix ? mol/l

Urine—Furfenorex;

arbitrary concentration(procedure)M = 229,31 g/molNPU04490U—Furfenorex; arb.c.(proc.) = ?

Urine—Furfenorex;

substance concentrationmicromole/literM = 229,31 g/molNPU02137U—Furfenorex; subst.c. = ? µmol/l

Urine—Furosemide;

arbitrary concentration(procedure)M = 330,75 g/molNPU02138U—Furosemide; arb.c.(proc.) = ?

Plasma—Furosemide;

substance concentrationmicromole/literM = 330,75 g/molNPU08791P—Furosemide; subst.c. = ? µmol/l

Urine—Furosemide;

substance concentrationmicromole/literM = 330,75 g/molNPU02141U—Furosemide; subst.c. = ? µmol/l

Plasma—Gabapentin;

substance concentrationmicromole/literM = 171,24 g/molNPU10155P—Gabapentin; subst.c. = ? µmol/l

Patient—Gemfibrozil(administered);

substance rate(oral administration)micromole/dayM = 250,35 g/molNPU10246Pt—Gemfibrozil(administered); subst.rate(p.o.) = ?µmol/d

Plasma—Gentamicin;

arbitrary concentration(procedure)Note: M: mean 463,57NPU12400P—Gentamicin; arb.c.(proc.) = ?

Urine—Gentamicin;

arbitrary concentration(procedure)Note: M: mean 463,57NPU10241U—Gentamicin; arb.c.(proc.) = ?

Cerebrospinal fluid—Gentamicin;

substance concentrationmicromole/literNote: M: mean 463,57NPU17433Csf—Gentamicin; subst.c. = ? µmol/l

Plasma—Gentamicin;

substance concentrationmicromole/literNote: M:mean 463,57NPU02164P—Gentamicin; subst.c. = ? µmol/l



Secretion(specification)—Gentamicin;

substance concentrationmicromole/literNote: M: mean 463,57NPU12921Secr(spec.)—Gentamicin; subst.c. = ? µmol/l

Urine—Gentamicin;

substance concentrationmicromole/literNote: M: mean 463,57NPU12920U—Gentamicin; subst.c. = ? µmol/l

Plasma—Glibenclamide;

substance concentrationmole/literM = 494,01 g/molNPU04799P—Glibenclamide; subst.c.= ? prefix ? mol/l

Urine—Glutethimide;

arbitrary concentration(procedure)M = 217,26 g/molNPU02270U—Glutethimide; arb.c.(proc.) = ?

Urine—Griseofulvin;

arbitrary concentration(procedure)M = 352,77 g/molNPU04394U—Griseofulvin; arb.c.(proc.) = ?

Plasma—Griseofulvin;

substance concentrationmole/literM = 352,77 g/molNPU04803P—Griseofulvin; subst.c.= ? prefix ? mol/l

Urine—Griseofulvin;

substance concentrationmole/literM = 352,77 g/molNPU04395U—Griseofulvin; subst.c.= ? prefix ? mol/l

Urine—Haemoleptic agent;

arbitrary concentration(list; procedure)NPU08594U—Haemoleptic agent; arb.c.(list; proc.)

Urine—Haloperidol;

arbitrary concentration(procedure)M = 375,88 g/molNPU02316U—Haloperidol; arb.c.(proc.) = ?

Plasma—Haloperidol;

substance concentrationnanomole/literM = 375,88 g/molNPU03937P—Haloperidol; subst.c. = ? nmol/l

Urine—Haloperidol;

substance concentrationnanomole/literM = 375,88 g/molNPU04582U—Haloperidol; subst.c. = ? nmol/l

Urine—Heptaminol;

arbitrary concentration(procedure)M = 145,24 g/molNPU04493U—Heptaminol; arb.c.(proc.) = ?

Urine—Heptaminol;

substance concentrationmicromole/literM = 145,24 g/molNPU02353U—Heptaminol; subst.c. = ? µmol/l

Urine—Histamine antagonist;

arbitrary concentration(list; procedure)NPU04586U—Histamine antagonist; arb.c.(list; proc.)NPU01269 U—Antazoline; arb.c.(proc.) = ?NPU01906 U—Diphenhydramine; arb.c.(proc.) = ?NPU02698 U—Mepyramine; arb.c.(proc.) = ?NPU03263 U—Promethazine; arb.c.(proc.) = ?

Urine—Histamine antagonist;

taxon(procedure)NPU04825U—Histamine antagonist; taxon(proc.) = ?

Urine—Hydralazine;

arbitrary concentration(procedure)M = 168,18 g/molNPU04396U—Hydralazine; arb.c.(proc.) = ?


518 H. OLESEN

Urine—Hydralazine;

substance concentrationmole/literM = 168,18 g/molNPU04397U—Hydralazine; subst.c.= ? prefix ? mol/l

Plasma—Hydralazine;

substance concentrationnanomole/literM = 168,18 g/molNPU04398P—Hydralazine; subst.c. = ? nmol/l

Urine—Hydrochlorothiazide;

arbitrary concentration(procedure)M = 297,72 g/molNPU02404U—Hydrochlorothiazide; arb.c.(proc.) = ?

Plasma—Hydrochlorothiazide;

substance concentrationmicromole/literM = 297,72 g/molNPU08793P—Hydrochlorothiazide; subst.c. = ? µmol/l

Urine—Hydrochlorothiazide;

substance concentrationmicromole/literM = 297,72 g/molNPU02407U—Hydrochlorothiazide; subst.c. = ? µmol/l

Urine—Hydrocodone;

arbitrary concentration(procedure)M = 299,36 g/molNPU02408U—Hydrocodone; arb.c.(proc.) = ?

Urine—Hydrocodone;

substance concentrationmole/literM = 299,36 g/molNPU04924U—Hydrocodone; subst.c.= ? prefix ? mol/l

Urine—Hydroflumethiazide;

arbitrary concentration(procedure)M = 331,29 g/molNPU04597U—Hydroflumethiazide; arb.c.(proc.) = ?

Urine—Hydroflumethiazide;

substance concentrationmicromole/literM = 331,29 g/molNPU04470U—Hydroflumethiazide; subst.c. = ? µmol/l

Urine—Hydromorphone;

arbitrary concentration(procedure)M = 285,33 g/molNPU04693U—Hydromorphone; arb.c.(proc.) = ?

Plasma—Hydromorphone;

substance concentrationmole/literM = 285,33 g/molNPU04399P—Hydromorphone; subst.c.= ? prefix ? mol/l

Urine—Hydromorphone;

substance concentrationmole/literM = 285,33 g/molNPU04473U—Hydromorphone; subst.c.= ? prefix ? mol/l

Urine—p-

Hydroxyamfetamine;arbitrary concentration(procedure)M = 151,21 g/molOther term(s): MethylthyramineNPU04492U—p-Hydroxyamfetamine; arb.c.(proc.) = ?

Urine—p-

Hydroxyamfetamine;substance concentrationmicromole/literM = 151,21 g/molOther term(s): MethylthyramineNPU02421U—p-Hydroxyamfetamine; subst.c. = ? µmol/l

Plasma—7-

Hydroxyamoxapine;substance concentrationnanomole/literNPU10268P—7-Hydroxyamoxapine; subst.c. = ? nmol/l



Plasma—8-

Hydroxyamoxapine;substance concentrationnanomole/literNPU10269P—8-Hydroxyamoxapine; subst.c. = ? nmol/l

Plasma—10-

Hydroxycarbamazepine;substance concentrationmicromole/literNPU10615P—10-Hydroxycarbamazepine; subst.c. = ? µmol/l

Urine—6-bbbbb-

Hydroxymetandienone;arbitrary concentration(procedure)NPU08597U—6-b-Hydroxymetandienone; arb.c.(proc.) = ?

Plasma—10-

Hydroxynortriptyline;substance concentrationnanomole/literNPU09093P—10-Hydroxynortriptyline; subst.c. = ? nmol/l

Urine—3'-

Hydroxystanozolol;arbitrary concentration(procedure)NPU08598U—3'-Hydroxystanozolol; arb.c.(proc.) = ?

Urine—Hydroxyzine;

arbitrary concentration(procedure)M = 374,92 g/molNPU09053U—Hydroxyzine; arb.c.(proc.) = ?

Plasma—Hydroxyzine;

substance concentrationmole/literM = 374,92 g/molNPU09051P—Hydroxyzine; subst.c.= ? prefix ? mol/l

Urine—Hydroxyzine;

substance concentrationmole/literM = 374,92 g/molNPU09052U—Hydroxyzine; subst.c.= ? prefix ? mol/l

Plasma—Ibuprofen;

substance concentrationmicromole/literM = 206,27 g/molNPU08794P—Ibuprofen; subst.c. = ? µmol/l

Patient—Imipramine(administered);

substance rate(oral administration)micromole/dayM = 280,41 g/molNPU10244Pt—Imipramine(administered); subst.rate(p.o.) = ?µmol/d

Urine—Imipramine;

arbitrary concentration(procedure)M = 280,41 g/molNPU02473U—Imipramine; arb.c.(proc.) = ?

Plasma—Imipramine;

substance concentrationnanomole/literM = 280,41 g/molNPU02472P—Imipramine; subst.c. = ? nmol/l

Urine—Imipramine;

substance concentrationnanomole/literM = 280,41 g/molNPU04798U—Imipramine; subst.c. = ? nmol/l

Plasma—Imipramine+Desipramine;

substance concentrationnanomole/literNote: M (imipramine) = 280,41 g/mol; M(desipramine) = 266,37 g/molNPU08627P—Imipramine+Desipramine; subst.c. = ? nmol/l

Urine—Imipraminoxide;

arbitrary concentration(procedure)M = 296,41 g/molOther term(s): Imipramine N-oxideNPU09076U—Imipraminoxide; arb.c.(proc.) = ?


520 H. OLESEN

Plasma—Imipraminoxide;

substance concentrationmole/literM = 296,41 g/molOther term(s): Imipramine N-oxideNPU09074P—Imipraminoxide; subst.c.= ? prefix ? mol/l

Urine—Imipraminoxide;

substance concentrationmole/literM = 296,41 g/molOther term(s): Imipramine N-oxideNPU09075U—Imipraminoxide; subst.c.= ? prefix ? mol/l

Urine—Indapamide;

substance concentrationmole/literM = 365,84 g/molNPU04496U—Indapamide; subst.c.= ? prefix ? mol/l

Plasma—Indometacin;

substance concentrationmole/literM = 357,81 g/molNPU08795P—Indometacin; subst.c.= ? prefix ? mol/l

Urine—Isocarboxazid;

arbitrary concentration(procedure)M = 231,25 g/molNPU09079U—Isocarboxazid; arb.c.(proc.) = ?

Plasma—Isocarboxazid;

substance concentrationmole/literM = 231,25 g/molNPU09077P—Isocarboxazid; subst.c.= ? prefix ? mol/l

Urine—Isocarboxazid;

substance concentrationmole/literM = 231,25 g/molNPU09078U—Isocarboxazid; subst.c.= ? prefix ? mol/l

Plasma—Isoniazide;

substance concentrationmicromole/literM = 137,15 g/molNPU04816P—Isoniazide; subst.c. = ? µmol/l

Urine—Isoniazide;

substance concentrationmicromole/literNPU16482U—Isoniazide; subst.c. = ? µmol/l

Plasma—Isopropanol;

substance concentrationmillimole/literM = 60,10 g/molNPU08796P—Isopropanol; subst.c. = ? mmol/l

Plasma—Isradipine;

substance concentrationnanomole/literM = 371,39 g/molNPU08797P—Isradipine; subst.c. = ? nmol/l

Urine—Ketobemidone;

arbitrary concentration(procedure)M = 247,33 g/molNPU02523U—Ketobemidone; arb.c.(proc.) = ?

Plasma—Ketobemidone;

substance concentrationmicromole/literM = 247,33 g/molNPU08798P—Ketobemidone; subst.c. = ? µmol/l

Urine—Ketobemidone;

substance concentrationmicromole/literM = 247,33 g/molNPU02524U—Ketobemidone; subst.c. = ? µmol/l

Urine—Labetalol;

arbitrary concentration(procedure)M = 328,41 g/molNPU04697U—Labetalol; arb.c.(proc.) = ?



Plasma—Labetalol;

substance concentrationmicromole/literM = 328,41 g/molNPU04234P—Labetalol; subst.c. = ? µmol/l

Urine—Labetalol;

substance concentrationmicromole/literM = 328,41 g/molNPU02540U—Labetalol; subst.c. = ? µmol/l

Patient—Lamotrigine(administered);

substance rate(oral administration)micromole/dayM = 256,09 g/molNPU10245Pt—Lamotrigine(administered); subst.rate(p.o.) = ?µmol/d

Plasma—Lamotrigine;

substance concentrationmicromole/literM = 256,09 g/molNPU08732P—Lamotrigine; subst.c. = ? µmol/l

Urine—Levomepromazine;

arbitrary concentration(procedure)M = 328,46 g/molNPU02598U—Levomepromazine; arb.c.(proc.) = ?

Urine—Levomepromazine;

substance concentrationmicromole/literM = 328,46 g/molNPU04800U—Levomepromazine; subst.c. = ? µmol/l

Plasma—Levomepromazine;

substance concentrationnanomole/literM = 328,46 g/molNPU04853P—Levomepromazine; subst.c. = ? nmol/l

Urine—Levorphanol;

arbitrary concentration(procedure)M = 257,38 g/molNPU04497U—Levorphanol; arb.c.(proc.) = ?

Urine—Levorphanol;

substance concentrationmicromole/literM = 257,38 g/molNPU02601U—Levorphanol; subst.c. = ? µmol/l

Plasma—Lidocaine;

substance concentrationmicromole/literM = 234,34 g/molNPU02602P—Lidocaine; subst.c. = ? µmol/l

Urine—Lofentanil;

arbitrary concentration(procedure)M = 408,54 g/molNPU04235U—Lofentanil; arb.c.(proc.) = ?

Plasma—Lofentanil;

substance concentrationmole/literM = 408,54 g/molNPU04237P—Lofentanil; subst.c.= ? prefix ? mol/l

Urine—Lofentanil;

substance concentrationmole/literM = 408,54 g/molNPU04236U—Lofentanil; subst.c.= ? prefix ? mol/l

Urine—Lofepramine;

arbitrary concentration(procedure)M = 418,97 g/molNPU09081U—Lofepramine; arb.c.(proc.) = ?

Plasma—Lofepramine;

substance concentrationnanomole/literM = 418,97 g/molNPU04854P—Lofepramine; subst.c. = ? nmol/l


522 H. OLESEN

Urine—Lofepramine;

substance concentrationnanomole/literM = 418,97 g/molNPU09080U—Lofepramine; subst.c. = ? nmol/l

Urine—Lorazepam;

arbitrary concentration(procedure)M = 321,16 g/molNPU02614U—Lorazepam; arb.c.(proc.) = ?

Urine—Lorazepam;

substance concentrationmicromole/literM = 321,16 g/molNPU04699U—Lorazepam; subst.c. = ? µmol/l

Plasma—Lorazepam;

substance concentrationnanomole/literM = 321,16 g/molNPU04855P—Lorazepam; subst.c. = ? nmol/l

Urine—Lormetazepam;

arbitrary concentration(procedure)M = 335,19 g/molNPU02615U—Lormetazepam; arb.c.(proc.) = ?

Urine—Lormetazepam;

substance concentrationmicromole/literM = 335,19 g/molNPU09064U—Lormetazepam; subst.c. = ? µmol/l

Plasma—Lormetazepam;

substance concentrationnanomole/literM = 335,19 g/molNPU09065P—Lormetazepam; subst.c. = ? nmol/l

Patient—Lovastatin(administered);

substance rate(oral administration)millimole/dayM = 404,55 g/molNPU10190Pt—Lovastatin(administered); subst.rate(p.o.) = ?mmol/d

Urine—Loxapine;

arbitrary concentration(procedure)M = 327,81 g/molNPU04238U—Loxapine; arb.c.(proc.) = ?

Plasma—Loxapine;

substance concentrationmole/literM = 327,81 g/molNPU04240P—Loxapine; subst.c.= ? prefix ? mol/l

Urine—Loxapine;

substance concentrationmole/literM = 327,81 g/molNPU04239U—Loxapine; subst.c.= ? prefix ? mol/l

Urine—Lysergide;

arbitrary concentration(procedure)M = 323,44 g/molOther term(s): LSDNPU04932U—Lysergide; arb.c.(proc.) = ?

Urine—Lysergide;

substance concentrationmole/literM = 323,44 g/molOther term(s): LSDNPU04933U—Lysergide; subst.c.= ? prefix ? mol/l

Urine—Lyserginate;

arbitrary concentration(procedure)Note: M(anion) = 267,31 g/molNPU04930U—Lyserginate; arb.c.(proc.) = ?

Urine—Lyserginate;

substance concentrationmole/literNote: M (anion) = 267,31 g/molNPU04931U—Lyserginate; subst.c.= ? prefix ? mol/l

Urine—Mannitol;

arbitrary concentration(procedure)M = 182,17 g/molNPU04515U—Mannitol; arb.c.(proc.) = ?



Urine—Mannitol;

substance concentrationmole/literM = 182,17 g/molNPU09344U—Mannitol; subst.c.= ? prefix ? mol/l

Urine—Maprotiline;

arbitrary concentration(procedure)M = 277,41 g/molNPU02688U—Maprotiline; arb.c.(proc.) = ?

Urine—Maprotiline;

substance concentrationmicromole/literM = 277,41 g/molNPU04802U—Maprotiline; subst.c. = ? µmol/l

Plasma—Maprotiline;

substance concentrationnanomole/literM = 277,41 g/molNPU04857P—Maprotiline; subst.c. = ? nmol/l

Urine—Meclozine;

arbitrary concentration(procedure)M = 390,96 g/molOther term(s): MeclizineNPU04241U—Meclozine; arb.c.(proc.) = ?

Plasma—Meclozine;

substance concentrationmole/literM = 390,96 g/molOther term(s): MeclizineNPU04243P—Meclozine; subst.c.= ? prefix ? mol/l

Urine—Meclozine;

substance concentrationmole/literM = 390,96 g/molOther term(s): MeclizineNPU04242U—Meclozine; subst.c.= ? prefix ? mol/l

Urine—Medazepam;

arbitrary concentration(procedure)M = 270,76 g/molNPU02689U—Medazepam; arb.c.(proc.) = ?

Urine—Mefenorex;

arbitrary concentration(procedure)M = 211,73 g/molNPU04498U—Mefenorex; arb.c.(proc.) = ?

Urine—Mefenorex;

substance concentrationmicromole/literM = 211,74 g/molNPU02694U—Mefenorex; subst.c. = ? µmol/l

Urine—Mefruside;

substance concentrationmole/literM = 382,90 g/molNPU04499U—Mefruside; subst.c.= ? prefix ? mol/l

Urine—Mephentermine;

substance concentrationmole/literM = 163,25 g/molNPU04500U—Mephentermine; subst.c.= ? prefix ? mol/l

Urine—Mepindolol;

arbitrary concentration(procedure)M = 262,36 g/molNPU04503U—Mepindolol; arb.c.(proc.) = ?

Urine—Meprobamate;

arbitrary concentration(procedure)M = 218,25 g/molNPU02697U—Meprobamate; arb.c.(proc.) = ?

Plasma—Meprobamate;

substance concentrationmicromole/literM = 218,25 g/molNPU02696P—Meprobamate; subst.c. = ? µmol/l


524 H. OLESEN

Urine—Meprobamate;

substance concentrationmicromole/literM = 218,25 g/molNPU03413U—Meprobamate; subst.c. = ? µmol/l

Urine—Mepyramine;

arbitrary concentration(procedure)M = 285,39 g/molNPU02698U—Mepyramine; arb.c.(proc.) = ?

Urine—Mepyramine;

substance concentrationmicromole/literM = 285,39 g/molNPU04804U—Mepyramine; subst.c. = ? µmol/l

Urine—Mersalyl;

substance concentrationmicromole/literM = 505,85 g/molNPU02705U—Mersalyl; subst.c. = ? µmol/l

Urine—Mesoridazine;

arbitrary concentration(procedure)M = 386,59 g/molNPU04244U—Mesoridazine; arb.c.(proc.) = ?

Plasma—Mesoridazine;

substance concentrationmole/literM = 386,59 g/molNPU04246P—Mesoridazine; subst.c.= ? prefix ? mol/l

Urine—Mesoridazine;

substance concentrationmole/literM = 386,59 g/molNPU04245U—Mesoridazine; subst.c.= ? prefix ? mol/l

Urine—Mestanolone;

arbitrary concentration(procedure)M = 304,46 g/molNPU04937U—Mestanolone; arb.c.(proc.) = ?

Urine—Mestanolone;

substance concentrationmole/literM = 304,46 g/molNPU04518U—Mestanolone; subst.c.= ? prefix ? mol/l

Urine—Mesterolone;

arbitrary concentration(procedure)M = 304,46 g/molNPU04519U—Mesterolone; arb.c.(proc.) = ?

Urine—Mesterolone;

substance concentrationnanomole/literM = 304,46 g/molNPU02708U—Mesterolone; subst.c. = ? nmol/l

Urine—Metamfetamine;

arbitrary concentration(procedure)M = 149,24 g/molNPU04520U—Metamfetamine; arb.c.(proc.) = ?

Urine—Metamfetamine;

substance concentrationmicromole/literM = 149,24 g/molNPU02711U—Metamfetamine; subst.c. = ? µmol/l

Urine—Metandienone;

arbitrary concentration(procedure)M = 300,42 g/molOther term(s): MethandrostenoloneNPU04521U—Metandienone; arb.c.(proc.) = ?

Urine—Metandienone;

substance concentrationnanomole/literM = 300,42 g/molOther term(s): MethandrostenoloneNPU02714U—Metandienone; subst.c. = ? nmol/l



Urine—Metaraminol;

arbitrary concentration(procedure)M = 167,21 g/molOther term(s): Hydroxynor(pseudo)ephedrineNPU04710U—Metaraminol; arb.c.(proc.) = ?

Plasma—Metaraminol;

substance concentrationnanomole/literM = 167,21 g/molOther term(s): Hydroxynor(pseudo)ephedrineNPU04247P—Metaraminol; subst.c. = ? nmol/l

Urine—Metaraminol;

substance concentrationnanomole/literM = 167,21 g/molOther term(s): Hydroxynor(pseudo)ephedrineNPU02715U—Metaraminol; subst.c. = ? nmol/l

Urine—Metenolone;

arbitrary concentration(procedure)M = 302,44 g/molNPU04504U—Metenolone; arb.c.(proc.) = ?

Urine—Metenolone;

substance concentrationnanomole/literM = 302,44 g/molOther term(s): MethenoloneNPU02718U—Metenolone; subst.c. = ? nmol/l

Urine—Methadone;

arbitrary concentration(procedure)M = 309,45 g/molNPU02722U—Methadone; arb.c.(proc.) = ?

Plasma—Methadone;

substance concentrationnanomole/literM = 309,45 g/molNPU04113P—Methadone; subst.c. = ? nmol/l

Urine—Methadone;

substance concentrationnanomole/literM = 309,45 g/molNPU02721U—Methadone; subst.c. = ? nmol/l

Urine—Methandriol;

arbitrary concentration(procedure)M = 304,46 g/molNPU04505U—Methandriol; arb.c.(proc.) = ?

Urine—Methandriol;

substance concentrationmole/literM = 304,46 g/molNPU04908U—Methandriol; subst.c.= ? prefix ? mol/l

Urine—Methaqualone;

arbitrary concentration(procedure)M = 250,29 g/molNPU02724U—Methaqualone; arb.c.(proc.) = ?

Plasma—Methaqualone;

substance concentrationmicromole/literM = 250,29 g/molNPU04836P—Methaqualone; subst.c. = ? µmol/l

Urine—Methaqualone;

substance concentrationmicromole/literM = 250,29 g/molNPU03490U—Methaqualone; subst.c. = ? µmol/l

Urine—Methohexital;

arbitrary concentration(procedure)M = 262,31 g/molNPU08801U—Methohexital; arb.c.(proc.) = ?

Plasma—Methohexital;

substance concentrationmole/literM = 262,31 g/molNPU08803P—Methohexital; subst.c.= ? prefix ? mol/l


526 H. OLESEN

Urine—Methohexital;

substance concentrationmole/literM = 262,31 g/molNPU08802U—Methohexital; subst.c.= ? prefix ? mol/l

Plasma—Methoxsalen;

substance concentrationmole/literM = 216,18 g/molNPU08799P—Methoxsalen; subst.c.= ? prefix ? mol/l

Urine—Methoxyphenamine;

arbitrary concentration(procedure)M = 179,25 g/molNPU04530U—Methoxyphenamine; arb.c.(proc.) = ?

Urine—Methoxyphenamine;

substance concentrationmicromole/literM = 179,25 g/molNPU02743U—Methoxyphenamine; subst.c. = ? µmol/l

Urine—2-

Methylamino-1(3,4-methylenedioxyphenyl)butane;arbitrary concentration(procedure)M = 207,27 g/molOther term(s): MBDBNPU08921U—2-Methylamino-1(3,4-methylenedioxyphenyl)butane; arb.c.(proc.) = ?

Urine—2-

Methylamino-1(3,4-methylenedioxyphenyl)butane;substance concentrationmicromole/literM = 207,27 g/molOther term(s): MBDBNPU08922U—2-Methylamino-1(3,4-methylenedioxyphenyl)butane; subst.c. = ? µmol/l

Urine—3,4-

Methylenedioxyamfetamine;arbitrary concentration(procedure)M = 179,22 g/molOther term(s): MDANPU04927U—3,4-Methylenedioxyamfetamine; arb.c.(proc.) = ?

Urine—3,4-

Methylenedioxyamfetamine;substance concentrationmicromole/literM = 179,25 g/molOther term(s): MDANPU04925U—3,4-Methylenedioxyamfetamine; subst.c. = ?µmol/l

Urine—3,4-

Methylenedioxyethylamfetamine;arbitrary concentration(procedure)M = 207,27 g/molOther term(s): MDEANPU08923U—3,4-Methylenedioxyethylamfetamine;arb.c.(proc.) = ?

Urine—3,4-

Methylenedioxyethylamfetamine;substance concentrationmicromole/literM = 207,27 g/molOther term(s): MDEANPU08924U—3,4-Methylenedioxyethylamfetamine; subst.c. =? µmol/l

Urine—3,4-

Methylenedioxymetamfetamine;arbitrary concentration(procedure)M = 193,25 g/molOther term(s): MDMA; EcstasyNPU04701U—3,4-Methylenedioxymetamfetamine; arb.c.(proc.) = ?

Urine—3,4-

Methylenedioxymetamfetamine;substance concentrationmicromole/literM = 193,25 g/molOther term(s): MDMA; EcstasyNPU04482U—3,4-Methylenedioxymetamfetamine; subst.c. = ?µmol/l

Urine—Methylephedrine;

arbitrary concentration(procedure)M = 179,25 g/molAuthority: BANNPU04533U—Methylephedrine; arb.c.(proc.) = ?



Urine—Methylephedrine;

substance concentrationmicromole/literM = 179,25 g/molAuthority: BANNPU02774U—Methylephedrine; subst.c. = ? µmol/l

Urine—Methylphenidate;

arbitrary concentration(procedure)M = 233,30 g/molNPU04516U—Methylphenidate; arb.c.(proc.) = ?

Urine—Methylphenidate;

substance concentrationmicromole/literM = 233,30 g/molNPU02800U—Methylphenidate; subst.c. = ? µmol/l

Urine—Methyltestosterone;

arbitrary concentration(procedure)M = 302,44 g/molNPU04517U—Methyltestosterone; arb.c.(proc.) = ?

Urine—Methyltestosterone;

substance concentrationnanomole/literM = 302,44 g/molNPU02803U—Methyltestosterone; subst.c. = ? nmol/l

Urine—Methyprylon;

arbitrary concentration(procedure)M = 183,26 g/molNPU02812U—Methyprylon; arb.c.(proc.) = ?

Urine—Meticillin;

arbitrary concentration(procedure)M = 402,40 g/molNPU10189U—Meticillin; arb.c.(proc.) = ?

Plasma—Metoclopramide;

substance concentrationmole/literM = 299,80 g/molNPU08800P—Metoclopramide; subst.c.= ? prefix ? mol/l

Plasma—Metopimazine;

substance concentrationmole/literM = 445,61 g/molNPU08804P—Metopimazine; subst.c.= ? prefix ? mol/l

Urine—Metoprolol;

arbitrary concentration(procedure)M = 267,38 g/molNPU04616U—Metoprolol; arb.c.(proc.) = ?

Plasma—Metoprolol;

substance concentrationmicromole/literM = 267,38 g/molNPU04858P—Metoprolol; subst.c. = ? µmol/l

Urine—Metoprolol;

substance concentrationmicromole/literM = 267,38 g/molNPU02815U—Metoprolol; subst.c. = ? µmol/l

Plasma—Metronidazole;

substance concentrationmole/literM = 171,16 g/molNPU08805P—Metronidazole; subst.c.= ? prefix ? mol/l

Plasma—Mexiletine;

substance concentrationmicromole/literM = 179,27 g/molNPU04859P—Mexiletine; subst.c. = ? µmol/l

Urine—Mianserin;

arbitrary concentration(procedure)M = 264,37 g/molNPU02816U—Mianserin; arb.c.(proc.) = ?

Urine—Mianserin;

substance concentrationmicromole/literM = 264,37 g/molNPU04806U—Mianserin; subst.c. = ? µmol/l


528 H. OLESEN

Plasma—Mianserin;

substance concentrationnanomole/literM = 264,37 g/molNPU04860P—Mianserin; subst.c. = ? nmol/l

Urine—Mibolerone;

arbitrary concentration(procedure)M = 302,46 g/molNPU04938U—Mibolerone; arb.c.(proc.) = ?

Urine—Mibolerone;

substance concentrationmicromole/literM = 302,46 g/molNPU04910U—Mibolerone; subst.c. = ? µmol/l

Urine—Midazolam;

arbitrary concentration(procedure)M = 325,77 g/molNPU04248U—Midazolam; arb.c.(proc.) = ?

Plasma—Midazolam;

substance concentrationnanomole/literM = 325,77 g/molNPU04250P—Midazolam; subst.c. = ? nmol/l

Urine—Midazolam;

substance concentrationnanomole/literM = 325,77 g/molNPU04249U—Midazolam; subst.c. = ? nmol/l

Plasma—Mirtazapine;

substance concentrationnanomole/literM = 300,81 g/molNPU14028P—Mirtazapine; subst.c. = ? nmol/l

Plasma—Mivacurium;

substance concentrationnanomole/literM = 1 029,275 g/molNPU04590P—Mivacurium; subst.c. = ? nmol/l

Urine—Moclobemide;

arbitrary concentration(procedure)M = 268,74 g/molNPU09083U—Moclobemide; arb.c.(proc.) = ?

Plasma—Moclobemide;

substance concentrationnanomole/literM = 268,74 g/molNPU08953P—Moclobemide; subst.c. = ? nmol/l

Urine—Moclobemide;

substance concentrationnanomole/literM = 268,74 g/molNPU09082U—Moclobemide; subst.c. = ? nmol/l

Urine—6-

Monoacetylmorphine;arbitrary concentration(procedure)M = 327,38 g/molNPU08927U—6-Monoacetylmorphine; arb.c.(proc.) = ?

Urine—6-

Monoacetylmorphine;substance concentrationmole/literM = 327,38 g/molNPU08928U—6-Monoacetylmorphine; subst.c.= ? prefix ?mol/l

Urine—Morazone;

arbitrary concentration(procedure)M = 377,47 g/molNPU04524U—Morazone; arb.c.(proc.) = ?

Urine—Morazone;

substance concentrationmicromole/literM = 377,47 g/molNPU02844U—Morazone; subst.c. = ? µmol/l



Urine—Morphine(non-complexed);

arbitrary concentration(procedure)M = 285,34 g/molAuthority: BANNPU02846U—Morphine(non-complexed); arb.c.(proc.) = ?

Urine—Morphine(non-complexed);

substance concentrationmicromole/literM = 285,34 g/molAuthority: BANNPU02849U—Morphine(non-complexed); subst.c. = ? µmol/l

Urine—Morphine(total);

arbitrary concentration(procedure)M = 285,34 g/molAuthority: BANNote: Total: non-glucuronidated and glucuronidatedNPU08985U—Morphine(tot.); arb.c.(proc.) = ?

Plasma—Morphine(total);

substance concentrationmicromole/literM = 285,34 g/molAuthority: BANNote: Total: non-glucuronidated and glucuronidatedNPU09345P—Morphine(tot.); subst.c. = ? µmol/l

Urine—Morphine(total);

substance concentrationmicromole/literM = 285,34 g/molAuthority: BANNote: Total: non-glucuronidated and glucuronidatedNPU08986U—Morphine(tot.); subst.c. = ? µmol/l

Plasma—Morphine(total);

substance concentrationnanomole/literM = 285,34 g/molAuthority: BANNote: Total: non-glucuronidated and glucuronidatedNPU10619P—Morphine(tot.); subst.c. = ? nmol/l

Urine—Morphine+analogue(non-complexed);

arbitrary concentration(procedure)Note: Morphine; Morphine-3-glucuronide; Morphine-6-glucuronide; Codeine; Diamorphine;Dihydrocodeine; Ethylmorphine; Hydrocodone;Hydromorphone; Levallorphan; Levophanol;Nalorphine; Normorphine; OxycodoneNPU08954U—Morphine+analogue(non-complexed);arb.c.(proc.) = ?

Urine—Morphine+analogue(non-complexed);

substance concentrationmicromole/literNote: Morphine; Morphine-3-glucuronide; Morphine-6-glucuronide; Codeine; Diamorphine;Dihydrocodeine; Ethylmorphine; Hydrocodone;Hydromorphone; Levallorphan; Levophanol;Nalorphine; Normorphine; OxycodoneNPU08988U—Morphine+analogue(non-complexed);subst.c. = ? µmol/l

Urine—Morphine+analogue;

arbitrary concentration(procedure)Note: Morphine; Morphine-3-glucuronide; Morphine-6-glucuronide; Codeine; Diamorphine;Dihydrocodeine; Ethylmorphine; Hydrocodone;Hydromorphone; Levallorphan; Levophanol;Nalorphine; Normorphine; OxycodoneNPU08990U—Morphine+analogue; arb.c.(proc.) = ?


substance concentrationmicromole/literNote: Morphine; Morphine-3-glucuronide; Morphine-6-glucuronide; Codeine; Diamorphine;Dihydrocodeine; Ethylmorphine; Hydrocodone;Hydromorphone; Levallorphan; Levophanol;Nalorphine; Normorphine; OxycodoneNPU08992U—Morphine+analogue; subst.c. = ? µmol/l


taxon(procedure)Note: Morphine; Morphine-3-glucuronide; Morphine-6-glucuronide; Codeine; Diamorphine;Dihydrocodeine; Ethylmorphine; Hydrocodone;Hydromorphone; Levallorphan; Levophanol;Nalorphine; Normorphine; OxycodoneNPU08991U—Morphine+analogue; taxon(proc.) = ?


530 H. OLESEN

Urine—Nadolol;

arbitrary concentration(procedure)M = 309,42 g/molNPU04555U—Nadolol; arb.c.(proc.) = ?

Urine—Nadolol;

substance concentrationmicromole/literM = 309,42 g/molNPU02873U—Nadolol; subst.c. = ? µmol/l

Urine—Nalbuphine;

arbitrary concentration(procedure)M = 357,46 g/molNPU04536U—Nalbuphine; arb.c.(proc.) = ?

Urine—Nalbuphine;

substance concentrationmicromole/literM = 357,46 g/molNPU02884U—Nalbuphine; subst.c. = ? µmol/l

Urine—Nalorphine;

arbitrary concentration(procedure)M = 311,38 g/molNPU04928U—Nalorphine; arb.c.(proc.) = ?

Urine—Nalorphine;

substance concentrationmole/literM = 311,38 g/molNPU04929U—Nalorphine; subst.c.= ? prefix ? mol/l

Urine—Nandrolone;

arbitrary concentration(procedure)M = 274,39 g/molNPU04539U—Nandrolone; arb.c.(proc.) = ?

Urine—Nandrolone;

substance concentrationnanomole/literM = 274,39 g/molNPU02887U—Nandrolone; subst.c. = ? nmol/l

Urine—Narcotic drug;

arbitrary concentration(list; procedure)NPU08766U—Narcotic drug; arb.c.(list; proc.)NPU01163 U—Amfetamine; arb.c.(proc.) = ?NPU08957 U—Cannabinol; arb.c.(proc.) = ?NPU01706 U—Cocaine; arb.c.(proc.) = ?NPU02523 U—Ketobemidone; arb.c.(proc.) = ?NPU02722 U—Methadone; arb.c.(proc.) = ?NPU08985 U—Morphine(tot.); arb.c.(proc.) = ?NPU08990 U—Morphine+analogue; arb.c.(proc.) = ?

Urine—Narcotic drug;

taxon(procedure)NPU08930U—Narcotic drug; taxon(proc.) = ?

Plasma—Nefazodone;

substance concentrationnanomole/literM = 470,01 g/molNPU14029P—Nefazodone; subst.c. = ? nmol/l

Urine—Neopterine;

arbitrary concentration(procedure)M = 253,22 g/molNPU04563U—Neopterine; arb.c.(proc.) = ?

Cerebrospinal fluid—Neopterine;

substance concentrationnanomole/literM = 253,22 g/molNPU12535Csf—Neopterine; subst.c. = ? nmol/l

Plasma—Neopterine;

substance concentrationnanomole/literM = 253,22 g/molNPU12533P—Neopterine; subst.c. = ? nmol/l

Urine—Neopterine;

substance concentrationnanomole/literM = 253,22 g/molNPU02892U—Neopterine; subst.c. = ? nmol/l



Plasma—Netilmicin;

arbitrary concentration(procedure)NPU12364P—Netilmicin; arb.c.(proc.) = ?

Cerebrospinal fluid—Netilmicin;

substance concentrationmicromole/literNPU12928Csf—Netilmicin; subst.c. = ? µmol/l

Plasma—Netilmicin;

substance concentrationmicromole/literM = 475,59 g/molNPU02893P—Netilmicin; subst.c. = ? µmol/l

Secretion(specification)—Netilmicin;

substance concentrationmicromole/literNPU12927Secr(spec.)—Netilmicin; subst.c. = ? µmol/l

System(specification)—Netilmicin;

substance concentrationmicromole/literNPU17527Syst(spec.)—Netilmicin; subst.c. = ? µmol/l

Urine—Netilmicin;

substance concentrationmicromole/literNPU12926U—Netilmicin; subst.c. = ? µmol/l

Urine—Neuroleptic drug;

arbitrary substance concentration(list;procedure)NPU08767U—Neuroleptic drug; arb.subst.c.(list; proc.)NPU01544 U—Chlorpromazine; arb.c.(proc.) = ?NPU01545 U—Chlorprothixene; arb.c.(proc.) = ?NPU02598 U—Levomepromazine; arb.c.(proc.) = ?NPU03262 U—Promazine; arb.c.(proc.) = ?NPU04644 U—Thioridazine; arb.c.(proc.) = ?

System(specification)—Neuroleptic drug;

taxon(procedure)Authority: QU60883NPU10281Syst(spec.)—Neuroleptic drug; taxon(proc.) = ?

Urine—Neuroleptic drug;

taxon(procedure)NPU08931U—Neuroleptic drug; taxon(proc.) = ?

Urine—Nicomorphine;

arbitrary concentration(procedure)M = 495,51 g/molNPU02908U—Nicomorphine; arb.c.(proc.) = ?

Urine—Nicomorphine;

substance concentrationmole/literM = 495,51 g/molNPU04911U—Nicomorphine; subst.c.= ? prefix ? mol/l

Urine—Nicotinamide;

substance concentrationmole/literM = 122,1 g/molOther term(s): NiacinamideNPU02909U—Nicotinamide; subst.c.= ? prefix ? mol/l

Urine—Nicotinate;

arbitrary concentration(procedure)Note: M (anion) = 122,11 g/molNPU04541U—Nicotinate; arb.c.(proc.) = ?

Urine—Nicotinate;

substance concentrationmole/literNote: M (anion) = 122,11 g/molNPU02911U—Nicotinate; subst.c.= ? prefix ? mol/l

Urine—Nicotine;

arbitrary concentration(procedure)M = 162,23 g/molAuthority: MartindaleNPU04540U—Nicotine; arb.c.(proc.) = ?

Urine—Nicotine;

substance concentrationmole/literM = 162,23 g/molAuthority: MartindaleNPU02910U—Nicotine; subst.c.= ? prefix ? mol/l


532 H. OLESEN

Urine—Nifenalol;

arbitrary concentration(procedure)M = 224,26 g/molNPU04542U—Nifenalol; arb.c.(proc.) = ?

Urine—Nikethamide;

arbitrary concentration(procedure)M = 178,23 g/molNPU04543U—Nikethamide; arb.c.(proc.) = ?

Urine—Nikethamide;

substance concentrationmicromole/literM = 178,23 g/molNPU02914U—Nikethamide; subst.c. = ? µmol/l

Urine—Nitrazepam;

arbitrary concentration(procedure)M = 281,27 g/molNPU02916U—Nitrazepam; arb.c.(proc.) = ?

Urine—Nitrazepam;

substance concentrationmicromole/literM = 281,27 g/molNPU04723U—Nitrazepam; subst.c. = ? µmol/l

Plasma—Nitrazepam;

substance concentrationnanomole/literM = 281,27 g/molNPU02915P—Nitrazepam; subst.c. = ? nmol/l

Urine—Nitrofurantoin;

arbitrary concentration(procedure)M = 238,16 g/molNPU10194U—Nitrofurantoin; arb.c.(proc.) = ?

Plasma—Nitroglycerin;

substance concentrationmole/literM = 227,09 g/molOther term(s): Glyceryl(tri)nitrateNPU08792P—Nitroglycerin; subst.c.= ? prefix ? mol/l

Urine—Nizatidine;

arbitrary concentration(procedure)M = 331,46 g/molNPU04251U—Nizatidine; arb.c.(proc.) = ?

Plasma—Nizatidine;

substance concentrationmicromole/literM = 331,46 g/molNPU04253P—Nizatidine; subst.c. = ? µmol/l

Urine—Nizatidine;

substance concentrationmicromole/literM = 331,46 g/molNPU04252U—Nizatidine; subst.c. = ? µmol/l

Plasma—Nordazepam;

substance concentrationnanomole/literOther term(s): DesmethyldiazepamNPU10303P—Nordazepam; subst.c. = ? nmol/l

Urine—Norethandrolone;

arbitrary concentration(procedure)M = 302,44 g/molNPU04565U—Norethandrolone; arb.c.(proc.) = ?

Urine—Norethandrolone;

substance concentrationnanomole/literM = 302,44 g/molNPU02920U—Norethandrolone; subst.c. = ? nmol/l

Urine—Norfenefrine;

arbitrary concentration(procedure)M = 153,18 g/molNPU04567U—Norfenefrine; arb.c.(proc.) = ?

Urine—Norfenefrine;

substance concentrationmole/literM = 153,18 g/molNPU02921U—Norfenefrine; subst.c.= ? prefix ? mol/l



Urine—Norfenfluramine;

substance concentrationmicromole/literM = 203,21 g/molNPU04568U—Norfenfluramine; subst.c. = ? µmol/l

Plasma—Norfluoxetine;

substance concentrationnanomole/literNPU17886P—Norfluoxetine; subst.c. = ? nmol/l

Urine—Norpethidine;

arbitrary concentration(procedure)M = 233,30 g/molNPU04571U—Norpethidine; arb.c.(proc.) = ?

Urine—Norpethidine;

substance concentrationmole/literM = 233,30 g/molNPU02922U—Norpethidine; subst.c.= ? prefix ? mol/l

Plasma—Norpropoxyphen;

substance concentrationmicromole/literNPU10766P—Norpropoxyphen; subst.c. = ? µmol/l

Urine—Nortriptyline;

arbitrary concentration(procedure)M = 263,38 g/molNPU02924U—Nortriptyline; arb.c.(proc.) = ?

Plasma—Nortriptyline;

substance concentrationnanomole/literM = 263,38 g/molNPU02923P—Nortriptyline; subst.c. = ? nmol/l

Urine—Nortriptyline;

substance concentrationnanomole/literM = 263,38 g/molNPU04813U—Nortriptyline; subst.c. = ? nmol/l

Urine—Octopamine;

substance concentrationmole/literM = 153,18 g/molNPU02927U—Octopamine; subst.c.= ? prefix ? mol/l

Plasma—Olanzapine;

substance concentrationnanomole/literM = 312,44 g/molNPU09358P—Olanzapine; subst.c.= ? nmol/l

Plasma—Opipramol;

substance concentrationnanomole/literM = 363,49 g/molNPU04837P—Opipramol; subst.c. = ? nmol/l

Urine—Oxandrolone;

arbitrary concentration(procedure)M = 306,43 g/molNPU04726U—Oxandrolone; arb.c.(proc.) = ?

Plasma—Oxandrolone;

substance concentrationnanomole/literM = 306,43 g/molNPU04254P—Oxandrolone; subst.c. = ? nmol/l

Urine—Oxandrolone;

substance concentrationnanomole/literM = 306,43 g/molNPU02974U—Oxandrolone; subst.c. = ? nmol/l

Urine—Oxazepam;

arbitrary concentration(procedure)M = 286,74 g/molNPU02975U—Oxazepam; arb.c.(proc.) = ?

Plasma—Oxazepam;

substance concentrationmicromole/literM = 286,74 g/molNPU04862P—Oxazepam; subst.c. = ? µmol/l


534 H. OLESEN

Urine—Oxazepam;

substance concentrationmicromole/literM = 286,72 g/molNPU04727U—Oxazepam; subst.c. = ? µmol/l

Patient—Oxcarbazepine(administered);

substance rate(oral administration)micromole/dayM = 252,27 g/molNPU10247Pt—Oxcarbazepine(administered); subst.rate(p.o.) =? µmol/d

Plasma—Oxcarbazepine;

substance concentrationmicromole/literM = 252,27 g/molNPU03902P—Oxcarbazepine; subst.c. = ? µmol/l

Urine—Oxcarbazepine;

substance concentrationmicromole/literM = 252,27 g/molNPU03989U—Oxcarbazepine; subst.c. = ? µmol/l

Urine—Oxedrine;

arbitrary concentration(procedure)M = 167,21 g/molAuthority: BANNPU04575U—Oxedrine; arb.c.(proc.) = ?

Urine—Oxedrine;

substance concentrationmole/literM = 167,21 g/molOther term(s): SynephrineAuthority: BANNPU02976U—Oxedrine; subst.c.= ? prefix ? mol/l

Urine—Oxprenolol;

arbitrary concentration(procedure)M = 265,35 g/molNPU04620U—Oxprenolol; arb.c.(proc.) = ?

Urine—Oxprenolol;

substance concentrationmicromole/literM = 265,35 g/molNPU03005U—Oxprenolol; subst.c. = ? µmol/l

Urine—Oxycodone;

arbitrary concentration(procedure)M = 315,36 g/molNPU04591U—Oxycodone; arb.c.(proc.) = ?

Urine—Oxycodone;

substance concentrationmicromole/literM = 315,36 g/molNPU04912U—Oxycodone; subst.c. = ? µmol/l

Urine—Oxymesterone;

arbitrary concentration(procedure)M = 318,44 g/molNPU04564U—Oxymesterone; arb.c.(proc.) = ?

Urine—Oxymesterone;

substance concentrationnanomole/literM = 318,44 g/molNPU03017U—Oxymesterone; subst.c. = ? nmol/l

Urine—Oxymetholone;

arbitrary concentration(procedure)M = 332,47 g/molNPU04730U—Oxymetholone; arb.c.(proc.) = ?

Plasma—Oxymetholone;

substance concentrationnanomole/literM = 332,47 g/molNPU04255P—Oxymetholone; subst.c. = ? nmol/l

Urine—Oxymetholone;

substance concentrationnanomole/literM = 332,47 g/molNPU03020U—Oxymetholone; subst.c. = ? nmol/l



Urine—Oxymorphone;

arbitrary concentration(procedure)M = 301,33 g/molNPU04256U—Oxymorphone; arb.c.(proc.) = ?

Plasma—Oxymorphone;

substance concentrationmole/literM = 301,33 g/molNPU04258P—Oxymorphone; subst.c.= ? prefix ? mol/l

Urine—Oxymorphone;

substance concentrationmole/literM = 301,33 g/molNPU04257U—Oxymorphone; subst.c.= ? prefix ? mol/l

Urine—Oxytetracycline;

arbitrary substance concentration(procedure)arbitrary unit/literM = 460,44 g/molNPU08824U—Oxytetracycline; arb.subst.c.(proc.) = ? arb.unit/l

Plasma—Oxytetracycline;

substance concentrationmole/literM = 460,44 g/molNPU08823P—Oxytetracycline; subst.c.= ? prefix ? mol/l

Urine—Oxytetracycline;

substance concentrationmole/literM = 460,44 g/molNPU08825U—Oxytetracycline; subst.c.= ? prefix ? mol/l

Patient—Paracetamol(administered);

substance rate(oral administration)millimole/dayM = 151,16 g/molNPU10248Pt—Paracetamol(administered); subst.rate(p.o.) = ?mmol/d

Urine—Paracetamol;

arbitrary concentration(procedure)M = 151,16 g/molNPU04596U—Paracetamol; arb.c.(proc.) = ?

Plasma—Paracetamol;

substance concentrationmicromole/literM = 151,16 g/molNPU03024P—Paracetamol; subst.c. = ? µmol/l

Urine—Paracetamol;

substance concentrationmicromole/literM = 151,16 g/molNPU04810U—Paracetamol; subst.c. = ? µmol/l

Plasma—Paramethadione;

substance concentrationmillimole/literM = 157,17 g/molNPU10200P—Paramethadione; subst.c. = ? mmol/l

Patient—Paroxetine(administered);

substance rate(oral administration)micromole/dayM = 329,37 g/molNPU10249Pt—Paroxetine(administered); subst.rate(p.o.) = ?µmol/d

Urine—Paroxetine;

arbitrary concentration(procedure)M = 329,37 g/molNPU09085U—Paroxetine; arb.c.(proc.) = ?

Plasma—Paroxetine;

substance concentrationnanomole/literM = 329,37 g/molNPU04863P—Paroxetine; subst.c. = ? nmol/l

Urine—Paroxetine;

substance concentrationnanomole/literM = 329,37 g/molNPU09084U—Paroxetine; subst.c. = ? nmol/l

Urine—Pemoline;

arbitrary concentration(procedure)M = 176,16 g/molNPU03031U—Pemoline; arb.c.(proc.) = ?


536 H. OLESEN

Urine—Pemoline;

substance concentrationmicromole/literM = 176,16 g/molNPU03034U—Pemoline; subst.c. = ? µmol/l

Urine—Penbutolol;

arbitrary concentration(procedure)M = 285,43 g/molNPU04621U—Penbutolol; arb.c.(proc.) = ?

Urine—Penbutolol;

substance concentrationmicromole/literM = 291,43 g/molNPU04512U—Penbutolol; subst.c. = ? µmol/l

Urine—Penicillin(specification);

substance concentrationmicromole/literNPU12942U—Penicillin(spec.); subst.c. = ? µmol/l

Cerebrospinal fluid—Penicillin;

substance concentrationmicromole/literNPU12939Csf—Penicillin; subst.c. = ? µmol/l

Plasma—Penicillin;

substance concentrationmicromole/literNPU12941P—Penicillin; subst.c. = ? µmol/l

Secretion(specification)—Penicillin;

substance concentrationmicromole/literNPU12940Secr(spec.)—Penicillin; subst.c. = ? µmol/l

System(specification)—Penicillin;

substance concentrationmicromole/literNPU17528Syst(spec.)—Penicillin; subst.c. = ? µmol/l

Urine—Penicillin;

substance concentrationmicromole/literNPU17532U—Penicillin; subst.c. = ? µmol/l

Urine—Pentazocine;

arbitrary concentration(procedure)M = 285,44 g/molNPU03035U—Pentazocine; arb.c.(proc.) = ?

Urine—Pentazocine;

substance concentrationmicromole/literM = 285,44 g/molNPU03038U—Pentazocine; subst.c. = ? µmol/l

Urine—Pentetrazol;

arbitrary concentration(procedure)M = 138,17 g/molNPU04598U—Pentetrazol; arb.c.(proc.) = ?

Urine—Pentetrazol;

substance concentrationmicromole/literM = 138,17 g/molNPU03041U—Pentetrazol; subst.c. = ? µmol/l

Urine—Pentobarbital;

arbitrary concentration(procedure)M = 226,3 g/molNPU03042U—Pentobarbital; arb.c.(proc.) = ?

Plasma—Pentobarbital;

substance concentrationmicromole/literM = 226,3 g/molNPU03954P—Pentobarbital; subst.c. = ? µmol/l

Urine—Pentobarbital;

substance concentrationmicromole/literM = 226,3 g/molNPU04733U—Pentobarbital; subst.c. = ? µmol/l



Plasma—Pentobarbital;

substance concentrationnanomole/literNPU16394P—Pentobarbital; subst.c. = ? nmol/l

Urine—Periciazine;

arbitrary concentration(procedure)M = 365,50 g/molNPU09056U—Periciazine; arb.c.(proc.) = ?

Plasma—Periciazine;

substance concentrationmole/literM = 365,50 g/molNPU09054P—Periciazine; subst.c.= ? prefix ? mol/l

Urine—Periciazine;

substance concentrationmole/literM = 365,50 g/molNPU09055U—Periciazine; subst.c.= ? prefix ? mol/l

Patient—Perphenazine(administered);

substance rate(oral administration)micromole/dayM = 403,97 g/molNPU10250Pt—Perphenazine(administered); subst.rate(p.o.) =? µmol/d

Urine—Perphenazine;

arbitrary concentration(procedure)M = 403,97 g/molNPU03048U—Perphenazine; arb.c.(proc.) = ?

Plasma—Perphenazine;

substance concentrationnanomole/literM = 403,97 g/molNPU03047P—Perphenazine; subst.c. = ? nmol/l

Urine—Perphenazine;

substance concentrationnanomole/literM = 403,97 g/molNPU04259U—Perphenazine; subst.c. = ? nmol/l

Urine—Pethidine;

arbitrary concentration(procedure)M = 247,34 g/molOther term(s): MeperidinNPU03049U—Pethidine; arb.c.(proc.) = ?

Urine—Pethidine;

substance concentrationmicromole/literM = 247,34 g/molOther term(s): MeperidinNPU03052U—Pethidine; subst.c. = ? µmol/l

Urine—Phenazocine;

arbitrary concentration(procedure)M = 321,44 g/molNPU04599U—Phenazocine; arb.c.(proc.) = ?

Urine—Phenazocine;

substance concentrationmicromole/literM = 321,44 g/molNPU03055U—Phenazocine; subst.c. = ? µmol/l

Urine—Phenazone;

arbitrary substance concentration(procedure)arbitrary unit/literM = 188,22 g/molOther term(s): AntipyrineNPU08808U—Phenazone; arb.subst.c.(proc.) = ? arb.unit/l

Plasma—Phenazone;

substance concentrationmole/literM = 188,22 g/molOther term(s): AntipyrineNPU08806P—Phenazone; subst.c.= ? prefix ? mol/l

Urine—Phenazone;

substance concentrationmole/literM = 188,22 g/molOther term(s): AntipyrineNPU08807U—Phenazone; subst.c.= ? prefix ? mol/l


538 H. OLESEN

Urine—Phendimetrazine;

arbitrary concentration(procedure)M = 191,26 g/molNPU04606U—Phendimetrazine; arb.c.(proc.) = ?

Urine—Phendimetrazine;

substance concentrationmicromole/literM = 191,26 g/molNPU03058U—Phendimetrazine; subst.c. = ? µmol/l

Urine—Phenethylamine;

arbitrary concentration(procedure)M = 121,18 g/molNPU04607U—Phenethylamine; arb.c.(proc.) = ?

Urine—Phenethylamine;

substance concentrationmicromole/literM = 121,18 g/molNPU04926U—Phenethylamine; subst.c. = ? µmol/l

Urine—Phenmetrazine;

arbitrary concentration(procedure)M = 177,24 g/molNPU04608U—Phenmetrazine; arb.c.(proc.) = ?

Urine—Phenmetrazine;

substance concentrationmicromole/literM = 177,24 g/molNPU03061U—Phenmetrazine; subst.c. = ? µmol/l

Patient—Phenobarbital(administered);

substance rate(oral administration)micromole/dayM = 232,24 g/molNPU10251Pt—Phenobarbital(administered); subst.rate(p.o.) =? µmol/d

Urine—Phenobarbital;

arbitrary concentration(procedure)M = 232,24 g/molNPU03063U—Phenobarbital; arb.c.(proc.) = ?

Plasma—Phenobarbital;

substance concentrationmicromole/literM = 232,24 g/molNPU03062P—Phenobarbital; subst.c. = ? µmol/l

Urine—Phenobarbital;

substance concentrationmicromole/literM = 232,24 g/molNPU04738U—Phenobarbital; subst.c. = ? µmol/l

Plasma—Phenobarbital;

substance concentrationnanomole/literNPU16390P—Phenobarbital; subst.c. = ? nmol/l

Urine—Phenolphthalein;

arbitrary concentration(procedure)M = 318,31 g/molNPU03064U—Phenolphthalein; arb.c.(proc.) = ?

Plasma—Phenoxymethylpenicillin;

substance concentrationmole/literM = 350,38 g/molOther term(s): Penicillin VNPU08809P—Phenoxymethylpenicillin; subst.c.= ? prefix ?mol/l

Plasma—Phenprocoumon;

substance concentrationmole/literM = 280,31 g/molNPU08810P—Phenprocoumon; subst.c.= ? prefix ? mol/l

Urine—Phentermine;

arbitrary concentration(procedure)M = 149,23 g/molNPU03065U—Phentermine; arb.c.(proc.) = ?

Urine—Phentermine;

substance concentrationmicromole/literM = 149,23 g/molNPU03068U—Phentermine; subst.c. = ? µmol/l



Urine—Phenylephrine;

arbitrary concentration(procedure)M = 167,17 g/molNPU04609U—Phenylephrine; arb.c.(proc.) = ?

Urine—Phenylephrine;

substance concentrationmole/literM = 167,17 g/molOther term(s): m-SynephrineNPU03081U—Phenylephrine; subst.c.= ? prefix ? mol/l

Urine—Phenylpropanolamine;

arbitrary concentration(procedure)M = 151,20 g/molAuthority: BANNPU04615U—Phenylpropanolamine; arb.c.(proc.) = ?

Urine—Phenylpropanolamine;

substance concentrationmicromole/literM = 151,20 g/molAuthority: BANNPU03084U—Phenylpropanolamine; subst.c. = ? µmol/l

Patient(Blood)—Phenytoin elimination;

half-life(procedure)hourNPU03810Pt(B)—Phenytoin elimination; half-life(proc.) = ? h

Patient—Phenytoin(administered);

substance rate(oral administration)micromole/dayM = 252,26 g/molNPU10252Pt—Phenytoin(administered); subst.rate(p.o.) = ?µmol/d

Plasma—Phenytoin(free);

substance concentrationmicromole/literM = 252,26 g/molNPU08971P—Phenytoin(free); subst.c. = ? µmol/l

Plasma—Phenytoin(total);

substance concentrationmicromole/literM = 252,26 g/molNPU03085P—Phenytoin(tot.); subst.c. = ? µmol/l

Urine—Pholedrine;

arbitrary concentration(procedure)M = 165,23 g/molNPU04617U—Pholedrine; arb.c.(proc.) = ?

Urine—Pholedrine;

substance concentrationmole/literM = 165,23 g/molNPU03086U—Pholedrine; subst.c.= ? prefix ? mol/l

Plasma—Pimozide;

substance concentrationmole/literM = 461,56 g/molNPU08811P—Pimozide; subst.c.= ? prefix ? mol/l

Urine—Pindolol;

arbitrary concentration(procedure)M = 248,32 g/molNPU04626U—Pindolol; arb.c.(proc.) = ?

Urine—Pindolol;

substance concentrationmicromole/literM = 248,32 g/molNPU04527U—Pindolol; subst.c. = ? µmol/l

Urine—Piperacillin;

arbitrary concentration(procedure)M = 517,56 g/molNPU10211U—Piperacillin; arb.c.(proc.) = ?

Urine—Pipradrol;

arbitrary concentration(procedure)M = 267,36 g/molNPU04618U—Pipradrol; arb.c.(proc.) = ?


540 H. OLESEN

Urine—Pipradrol;

substance concentrationmicromole/literM = 267,36 g/molNPU03177U—Pipradrol; subst.c. = ? µmol/l

Urine—Piretanide;

substance concentrationmicromole/literM = 362,41 g/molNPU04619U—Piretanide; subst.c. = ? µmol/l

Urine—Piroxicam;

arbitrary concentration(procedure)M = 331,35 g/molNPU04260U—Piroxicam; arb.c.(proc.) = ?

Plasma—Piroxicam;

substance concentrationmole/literM = 331,35 g/molNPU04262P—Piroxicam; subst.c.= ? prefix ? mol/l

Urine—Piroxicam;

substance concentrationmole/literM = 331,35 g/molNPU04261U—Piroxicam; subst.c.= ? prefix ? mol/l

Urine—Practolol;

arbitrary concentration(procedure)M = 266,34 g/molNPU03231U—Practolol; arb.c.(proc.) = ?

Urine—Practolol;

substance concentrationmicromole/literM = 266,34 g/molNPU04623U—Practolol; subst.c. = ? µmol/l

Urine—Prasterone;

arbitrary concentration(procedure)M = 288,41 g/molOther term(s): Dehydroepiandrosterone; DHEANPU09103U—Prasterone; arb.c.(proc.) = ?

Urine—Prazosin;

arbitrary concentration(procedure)M = 383,41 g/molNPU04263U—Prazosin; arb.c.(proc.) = ?

Plasma—Prazosin;

substance concentrationmole/literM = 383,41 g/molNPU04265P—Prazosin; subst.c.= ? prefix ? mol/l

Urine—Prazosin;

substance concentrationmole/literM = 383,41 g/molNPU04264U—Prazosin; subst.c.= ? prefix ? mol/l

Plasma—Prednisolone;

substance concentrationmole/literM = 360,44 g/molNPU08812P—Prednisolone; subst.c.= ? prefix ? mol/l

Plasma—Prednisone;

substance concentrationmole/literM = 358,44 g/molNPU08813P—Prednisone; subst.c.= ? prefix ? mol/l

Plasma—Pregnanolone;

substance concentrationnanomole/literM = 318,50 g/molOther term(s): PregnanoloneNPU04061P—Pregnanolone; subst.c. = ? nmol/l

Patient—Primidone(administered);

substance rate(oral administration)micromole/dayM = 218,25 g/molNPU10253Pt—Primidone(administered); subst.rate(p.o.) = ?µmol/d



Urine—Primidone;

arbitrary concentration(procedure)M = 218,25 g/molNPU04838U—Primidone; arb.c.(proc.) = ?

Plasma—Primidone;

substance concentrationmicromole/literM = 218,25 g/molNPU03235P—Primidone; subst.c. = ? µmol/l

Urine—Primidone;

substance concentrationmicromole/literM = 218,25 g/molNPU04839U—Primidone; subst.c. = ? µmol/l

Plasma—Primidone+Phenobarbital;

substance concentrationmicromole/literNote: M (Primidone) = 218,25 g/mol;M (Phenobarbital) = 232,24 g/molNPU09346P—Primidone+Phenobarbital; subst.c. = ? µmol/l

Urine—Probenecid;

arbitrary concentration(procedure)M = 285,36 g/molNPU04630U—Probenecid; arb.c.(proc.) = ?

Urine—Probenecid;

substance concentrationmicromole/literM = 285,36 g/molNPU03240U—Probenecid; subst.c. = ? µmol/l

Urine—Procainamide;

arbitrary concentration(procedure)M = 235,33 g/molNPU04631U—Procainamide; arb.c.(proc.) = ?

Plasma—Procainamide;

substance concentrationmicromole/literM = 235,33 g/molNPU03241P—Procainamide; subst.c. = ? µmol/l

Plasma—Procainamide+Acecainide;

substance concentrationmicromole/literNote: M (procainamide) = 235,3 g/molNPU03956P—Procainamide+Acecainide; subst.c. = ? µmol/l

Urine—Prolintane;

arbitrary concentration(procedure)M = 217,35 g/molNPU04632U—Prolintane; arb.c.(proc.) = ?

Urine—Prolintane;

substance concentrationmicromole/literM = 217,35 g/molNPU03261U—Prolintane; subst.c. = ? µmol/l

Urine—Promazine;

arbitrary concentration(procedure)M = 284,41 g/molNPU03262U—Promazine; arb.c.(proc.) = ?

Urine—Promazine;

substance concentrationmicromole/literM = 284,41 g/molNPU04817U—Promazine; subst.c. = ? µmol/l

Urine—Promethazine;

arbitrary concentration(procedure)M = 284,41 g/molNPU03263U—Promethazine; arb.c.(proc.) = ?

Urine—Promethazine;

substance concentrationmole/literM = 284,41 g/molNPU04819U—Promethazine; subst.c.= ? prefix ? mol/l

Urine—Propafenone;

arbitrary concentration(procedure)M = 341,45 g/molNPU04266U—Propafenone; arb.c.(proc.) = ?


542 H. OLESEN

Plasma—Propafenone;

substance concentrationmicromole/literM = 341,45 g/molNPU04268P—Propafenone; subst.c. = ? µmol/l

Urine—Propafenone;

substance concentrationmicromole/literM = 341,45 g/molNPU04267U—Propafenone; subst.c. = ? µmol/l

Urine—Propranolol;

arbitrary concentration(procedure)M = 259,35 g/molNPU03266U—Propranolol; arb.c.(proc.) = ?

Plasma—Propranolol;

substance concentrationmicromole/literM = 259,35 g/molNPU04964P—Propranolol; subst.c. = ? µmol/l

Urine—Propranolol;

substance concentrationmicromole/literM = 259,35 g/molNPU03269U—Propranolol; subst.c. = ? µmol/l

Urine—Propylhexedrine;

arbitrary concentration(procedure)M = 155,28 g/molNPU04633U—Propylhexedrine; arb.c.(proc.) = ?

Urine—Propylhexedrine;

substance concentrationmicromole/literM = 155,28 g/molNPU03272U—Propylhexedrine; subst.c. = ? µmol/l

Urine—Propyphenazone;

arbitrary concentration(procedure)M = 230,31 g/molNPU08925U—Propyphenazone; arb.c.(proc.) = ?

Urine—Propyphenazone;

substance concentrationmole/literM = 230,31 g/molNPU08926U—Propyphenazone; subst.c.= ? prefix ? mol/l

Urine—Protriptyline;

arbitrary concentration(procedure)M = 263,37 g/molNPU09087U—Protriptyline; arb.c.(proc.) = ?

Plasma—Protriptyline;

substance concentrationnanomole/literM = 263,37 g/molNPU04867P—Protriptyline; subst.c. = ? nmol/l

Urine—Protriptyline;

substance concentrationnanomole/literM = 263,37 g/molNPU09086U—Protriptyline; subst.c. = ? nmol/l

Plasma—Proxyphylline;

substance concentrationmicromole/literM = 238,24 g/molNPU08814P—Proxyphylline; subst.c. = ? µmol/l

Urine—Pseudoephedrine;

arbitrary concentration(procedure)M = 165,23 g/molNPU04634U—Pseudoephedrine; arb.c.(proc.) = ?

Urine—Pseudoephedrine;

substance concentrationmicromole/literM = 165,23 g/molNPU03311U—Pseudoephedrine; subst.c. = ? µmol/l

Plasma—Pyrazinamide;

substance concentrationmicromole/literM = 123,11 g/molNPU08815P—Pyrazinamide; subst.c. = ? µmol/l



Urine—Pyrazinamide;

substance concentrationmicromole/literNPU16483U—Pyrazinamide; subst.c. = ? µmol/l

Urine—Pyrimethamine;

arbitrary concentration(procedure)M = 248,71 g/molNPU04269U—Pyrimethamine; arb.c.(proc.) = ?

Plasma—Pyrimethamine;

substance concentrationmole/literM = 248,71 g/molNPU04271P—Pyrimethamine; subst.c.= ? prefix ? mol/l

Urine—Pyrimethamine;

substance concentrationmole/literM = 248,71 g/molNPU04270U—Pyrimethamine; subst.c.= ? prefix ? mol/l

Urine—Pyrovalerone;

arbitrary concentration(procedure)M = 245,26 g/molNPU04635U—Pyrovalerone; arb.c.(proc.) = ?

Urine—Pyrovalerone;

substance concentrationmole/literM = 245,26 g/molNPU03326U—Pyrovalerone; subst.c.= ? prefix ? mol/l

Urine—Quinethazone;

arbitrary concentration(procedure)M = 289,76 g/molNPU04636U—Quinethazone; arb.c.(proc.) = ?

Plasma—Quinidine;

substance concentrationmicromole/literM = 360,5 g/molOther term(s): ChinidineAuthority: BANNPU03349P—Quinidine; subst.c. = ? µmol/l

Plasma—Quinine;

substance concentrationmicromole/literM = 324,41 g/molAuthority: BANNPU03350P—Quinine; subst.c. = ? µmol/l

Plasma—Remoxipride;

substance concentrationmicromole/literM = 371,27 g/molNPU04119P—Remoxipride; subst.c. = ? µmol/l

Urine—Remoxipride;

substance concentrationmicromole/literM = 371,27 g/molNPU04120U—Remoxipride; subst.c.= ? µmol/l

Urine—Reserpine;

arbitrary concentration(procedure)M = 608,69 g/molNPU04272U—Reserpine; arb.c.(proc.) = ?

Plasma—Reserpine;

substance concentrationmole/literM = 608,69 g/molNPU04274P—Reserpine; subst.c.= ? prefix ? mol/l

Urine—Reserpine;

substance concentrationmole/literM = 608,69 g/molNPU04273U—Reserpine; subst.c.= ? prefix ? mol/l

Urine—Rhein;

arbitrary concentration(procedure)M = 284,22 g/molNPU04820U—Rhein; arb.c.(proc.) = ?

Urine—Rhein;

substance concentrationmole/literM = 284,22 g/molNPU04821U—Rhein; subst.c.= ? prefix ? mol/l


544 H. OLESEN

Plasma—Rifampicin;

arbitrary concentration(procedure)NPU12401P—Rifampicin; arb.c.(proc.) = ?

Urine—Rifampicin;

arbitrary concentration(procedure)M = 822,96 g/molNPU04275U—Rifampicin; arb.c.(proc.) = ?

Plasma—Rifampicin;

substance concentrationmicromole/literM = 822,96 g/molOther term(s): RifampinNPU04277P—Rifampicin; subst.c. = ? µmol/l

Urine—Rifampicin;

substance concentrationmicromole/literM = 822,96 g/molNPU04276U—Rifampicin; subst.c. = ? µmol/l

Urine—Risperidone;

arbitrary concentration(procedure)M = 410,49 g/molNPU09047U—Risperidone; arb.c.(proc.) = ?

Plasma—Risperidone;

substance concentrationnanomole/literM = 410,49 g/molNPU04868P—Risperidone; subst.c. = ? nmol/l

Urine—Risperidone;

substance concentrationnanomole/literM = 410,49 g/molNPU09046U—Risperidone; subst.c. = ? nmol/l

Plasma—Salbutamol;

arbitrary concentration(procedure)M = 239,31 g/molNPU10263P—Salbutamol; arb.c.(proc.) = ?

Urine—Salbutamol;

arbitrary concentration(procedure)M = 239,31 g/molNPU04637U—Salbutamol; arb.c.(proc.) = ?

Urine—Salicylate;

arbitrary concentration(procedure)Note: M (anion) = 137,12 g/molNPU03384U—Salicylate; arb.c.(proc.) = ?

Urine—Salicylate;

substance concentrationmole/literNote: M (anion) = 137,12 g/molNPU04811U—Salicylate; subst.c.= ? prefix ? mol/l

Plasma—Salicylate;

substance concentrationmillimole/literNote: M (anion) = 137,12 g/molNPU03383P—Salicylate; subst.c. = ? mmol/l

Urine—Salmeterol;

arbitrary concentration(procedure)M = 415,57 g/molNPU04639U—Salmeterol; arb.c.(proc.) = ?

Plasma—Sertraline;

substance concentrationnanomole/literM = 306,23 g/molNPU09364P—Sertraline; subst.c. = ? nmol/l

Patient—Simvastatin(administered);

substance rate(oral administration)micromole/dayOther term(s): ZocorNPU10254Pt—Simvastatin(administered); subst.rate(p.o.) = ?µmol/d

Urine—Sotalol;

arbitrary concentration(procedure)M = 272,36 g/molNPU08674U—Sotalol; arb.c.(proc.) = ?



Plasma—Sotalol;

substance concentrationmicromole/literM = 272,36 g/molNPU04628P—Sotalol; subst.c. = ? µmol/l

Urine—Sotalol;

substance concentrationmicromole/literM = 272,36 g/molNPU03442U—Sotalol; subst.c. = ? µmol/l

Plasma—Spiramycin;

substance concentrationmole/literNPU08816P—Spiramycin; subst.c.= ? prefix ? mol/l

Plasma—Spironolactone;

substance concentrationmicromole/literM = 416,59 g/molNPU04640P—Spironolactone; subst.c. = ? µmol/l

Urine—Spironolactone;

substance concentrationmicromole/literM = 416,59 g/molNPU03468U—Spironolactone; subst.c. = ? µmol/l

Urine—Stanozolol;

arbitrary concentration(procedure)M = 328,48 g/molNPU04641U—Stanozolol; arb.c.(proc.) = ?

Urine—Stanozolol;

substance concentrationnanomole/literM = 328,48 g/molNPU03471U—Stanozolol; subst.c. = ? nmol/l

Plasma—Streptomycin;

substance concentrationmicromole/literM = 581,58 g/molNPU10239P—Streptomycin; subst.c. = ? µmol/l

Urine—Strychnine;

arbitrary concentration(procedure)M = 334,42 g/molNPU04642U—Strychnine; arb.c.(proc.) = ?

Urine—Strychnine;

substance concentrationmicromole/literM = 334,42 g/molNPU03497U—Strychnine; subst.c. = ? µmol/l

Urine—Sufentanil;

arbitrary concentration(procedure)M = 386,56 g/molNPU04278U—Sufentanil; arb.c.(proc.) = ?

Plasma—Sufentanil;

substance concentrationmole/literM = 386,56 g/molNPU04280P—Sufentanil; subst.c.= ? prefix ? mol/l

Urine—Sufentanil;

substance concentrationmole/literM = 386,56 g/molNPU04279U—Sufentanil; subst.c.= ? prefix ? mol/l

Plasma—Sulfadiazine;

substance concentrationmole/literM = 250,28 g/molNPU08817P—Sulfadiazine; subst.c.= ? prefix ? mol/l

Plasma—Sulfadimidine;

substance concentrationmole/literM = 278,33 g/molOther term(s): SulfamethazineNPU08819P—Sulfadimidine; subst.c.= ? prefix ? mol/l

Plasma—Sulfamerazine;

substance concentrationmole/literM = 264,31 g/molNPU08818P—Sulfamerazine; subst.c.= ? prefix ? mol/l


546 H. OLESEN

Plasma—Sulfamethoxazole;

substance concentrationmicromole/literM = 253,28 g/molNPU10210P—Sulfamethoxazole; subst.c. = ? µmol/l

Urine—Sulpiride;

arbitrary concentration(procedure)M = 341,43 g/molNPU09050U—Sulpiride; arb.c.(proc.) = ?

Plasma—Sulpiride;

substance concentrationmole/literM = 341,43 g/molNPU09048P—Sulpiride; subst.c.= ? prefix ? mol/l

Urine—Sulpiride;

substance concentrationmole/literM = 341,43 g/molNPU09049U—Sulpiride; subst.c.= ? prefix ? mol/l

Plasma—Sultiame;

substance concentrationmicromole/literM = 290,36 g/molNPU10196P—Sultiame; subst.c. = ? µmol/l

Urine—Temazepam;

arbitrary concentration(procedure)M = 300,73 g/molNPU04281U—Temazepam; arb.c.(proc.) = ?

Urine—Temazepam;

substance concentrationmicromole/literM = 300,73 g/molNPU04282U—Temazepam; subst.c. = ? µmol/l

Plasma—Temazepam;

substance concentrationnanomole/literM = 300,73 g/molNPU04283P—Temazepam; subst.c. = ? nmol/l

Urine—Terbutaline;

arbitrary concentration(procedure)M = 225,29 g/molNPU04883U—Terbutaline; arb.c.(proc.) = ?

Plasma—Terbutaline;

substance concentrationmole/literM = 225,29 g/molNPU04284P—Terbutaline; subst.c.= ? prefix ? mol/l

Urine—Terbutaline;

substance concentrationmole/literM = 225,29 g/molNPU04877U—Terbutaline; subst.c.= ? prefix ? mol/l

Urine—Terfenadine;

arbitrary concentration(procedure)M = 471,68 g/molNPU04285U—Terfenadine; arb.c.(proc.) = ?

Plasma—Terfenadine;

substance concentrationmole/literM = 471,68 g/molNPU04287P—Terfenadine; subst.c.= ? prefix ? mol/l

Urine—Terfenadine;

substance concentrationmole/literM = 471,68 g/molNPU04286U—Terfenadine; subst.c.= ? prefix ? mol/l

Urine—Tertatolol;

arbitrary concentration(procedure)M = 295,45 g/molAuthority: IFCC/C-LDA; INNNPU14147U—Tertatolol; arb.c.(proc.) = ?

Urine—Tertatolol;

substance concentrationmicromole/literM = 295,45 g/molNPU04643U—Tertatolol; subst.c. = ? µmol/l



Urine—Testosterone;

substance concentrationnanomole/literM = 288,41 g/molAuthority: IUPAC-IUB 84NPU03548U—Testosterone; subst.c. = ? nmol/l

Urine—Tetracycline;

arbitrary substance concentration(procedure)arbitrary unit/literM = 444,44 g/molNPU08827U—Tetracycline; arb.subst.c.(proc.) = ? arb.unit/l

Plasma—Tetracycline;

substance concentrationmole/literM = 444,44 g/molNPU08826P—Tetracycline; subst.c.= ? prefix ? mol/l

Urine—Tetracycline;

substance concentrationmole/literM = 444,44 g/molNPU08828U—Tetracycline; subst.c.= ? prefix ? mol/l

Urine—ddddd-6-

Tetrahydrocannabinol;arbitrary concentration(procedure)Note: Minor (< 1 %) active constituent in Marihuana(Hashish)NPU09000U—d-6-Tetrahydrocannabinol; arb.c.(proc.) = ?

Urine—Tetrahydrocannabinol;

arbitrary concentration(procedure)Other term(s): Dronabinol; Delta-1-Tetrahydrocannabinol; Delta-9-TetrahydrocannabinolNote: Only major active constituent in Marihuana(Hashish)NPU08997U—Tetrahydrocannabinol; arb.c.(proc.) = ?

Urine—Tetrahydrocannabinol;

substance concentrationnanomole/literOther term(s): Dronabinol; Delta-1-Tetrahydrocannabinol; Delta-9-TetrahydrocannabinolNote: Only major active constituent in Marihuana(Hashish)NPU08998U—Tetrahydrocannabinol; subst.c. = ? nmol/l

Plasma—Theophylline;

substance concentrationmicromole/literM = 180,17 g/molAuthority: BANNPU03554P—Theophylline; subst.c. = ? µmol/l

Urine—Thiamine;

arbitrary substance concentration(procedure)arbitrary unit/literM = 300,81 g/molNPU08830U—Thiamine; arb.subst.c.(proc.) = ? arb.unit/l

Plasma—Thiamine;

substance concentrationmole/literM = 300,81 g/molNPU08829P—Thiamine; subst.c.= ? prefix ? mol/l

Urine—Thiamine;

substance concentrationmole/literM = 300,81 g/molNPU08831U—Thiamine; subst.c.= ? prefix ? mol/l

Urine—Thiopental;

arbitrary concentration(procedure)M = 242,34 g/molNPU08677U—Thiopental; arb.c.(proc.) = ?

Plasma—Thiopental;

substance concentrationmicromole/literM = 242,34 g/molNPU04830P—Thiopental; subst.c. = ? µmol/l

Urine—Thiopental;

substance concentrationmicromole/literM = 242,34 g/molNPU04831U—Thiopental; subst.c. = ? µmol/l

Urine—Thioridazine;

arbitrary concentration(procedure)M = 370,58 g/molNPU04644U—Thioridazine; arb.c.(proc.) = ?


548 H. OLESEN

Plasma—Thioridazine;

substance concentrationmicromole/literM = 370,58 g/molNPU04115P—Thioridazine; subst.c. = ? µmol/l

Urine—Thioridazine;

substance concentrationmicromole/literM = 370,58 g/molNPU03556U—Thioridazine; subst.c. = ? µmol/l

Urine—Thiotepa;

arbitrary concentration(procedure)M = 189,22 g/molNPU04288U—Thiotepa; arb.c.(proc.) = ?

Plasma—Thiotepa;

substance concentrationmole/literM = 189,22 g/molNPU04290P—Thiotepa; subst.c.= ? prefix ? mol/l

Urine—Thiotepa;

substance concentrationmole/literM = 189,22 g/molNPU04289U—Thiotepa; subst.c.= ? prefix ? mol/l

Plasma—Tiagabine;

substance concentrationnanomole/literM = 375,56 g/molNPU10232P—Tiagabine; subst.c. = ? nmol/l

Urine—Timolol;

arbitrary concentration(procedure)M = 316,42 g/molNPU04629U—Timolol; arb.c.(proc.) = ?

Urine—Timolol;

substance concentrationmicromole/literM = 316,42 g/molNPU04548U—Timolol; subst.c. = ? µmol/l

Plasma—Tiotixene;

substance concentrationmicromole/literM = 443,63 g/molNPU03788P—Tiotixene; subst.c. = ? µmol/l

Urine—Tiotixene;

substance concentrationmicromole/literM = 443,63 g/molNPU03741U—Tiotixene; subst.c. = ? µmol/l

Plasma—Tobramycin;

arbitrary concentration(procedure)NPU12367P—Tobramycin; arb.c.(proc.) = ?

Cerebrospinal fluid—Tobramycin;

substance concentrationmicromole/literNPU12923Csf—Tobramycin; subst.c. = ? µmol/l

Plasma—Tobramycin;

substance concentrationmicromole/literM = 467,52 g/molNPU03586P—Tobramycin; subst.c. = ? µmol/l

Secretion(specification)—Tobramycin;

substance concentrationmicromole/literNPU12924Secr(spec.)—Tobramycin; subst.c. = ? µmol/l

Urine—Tobramycin;

substance concentrationmicromole/literNPU12925U—Tobramycin; subst.c. = ? µmol/l

Plasma—Tocofersolan;

substance concentrationmicromole/literM = 430,69 g/molNPU03587P—Tocofersolan; subst.c. = ? µmol/l



Urine—Tocofersolan;

substance concentrationmicromole/literM = 430,69 g/molNPU03588U—Tocofersolan; subst.c. = ? µmol/l

Plasma—Tolbutamide;

substance concentrationmole/literM = 270,34 g/molNPU08832P—Tolbutamide; subst.c.= ? prefix ? mol/l

Plasma—Topiramate;

substance concentrationmicromole/literM = 339,37 g/molNPU09119P—Topiramate; subst.c. = ? µmol/l

Urine—Tramadol;

arbitrary concentration(procedure)M = 263,39 g/molNPU04549U—Tramadol; arb.c.(proc.) = ?

Urine—Tramadol;

substance concentrationmicromole/literM = 263,39 g/molNPU04551U—Tramadol; subst.c. = ? µmol/l

Urine—Tranquilizing drug;

arbitrary concentration(list; procedure)NPU04829U—Tranquilizing drug; arb.c.(list; proc.)NPU01151 U—Alprazolam; arb.c.(proc.) = ?NPU01402 U—Bromazepam; arb.c.(proc.) = ?NPU01534 U—Chlordiazepoxide; arb.c.(proc.) = ?NPU04843 U—Clobazam; arb.c.(proc.) = ?NPU01880 U—Diazepam; arb.c.(proc.) = ?NPU02062 U—Flunitrazepam; arb.c.(proc.) = ?NPU02614 U—Lorazepam; arb.c.(proc.) = ?NPU02916 U—Nitrazepam; arb.c.(proc.) = ?NPU02975 U—Oxazepam; arb.c.(proc.) = ?

Urine—Tranquilizing drug;

taxon(procedure)NPU04662U—Tranquilizing drug; taxon(proc.) = ?

Urine—Tranylcypromine;

arbitrary concentration(procedure)M = 133,19 g/molNPU04759U—Tranylcypromine; arb.c.(proc.) = ?

Plasma—Tranylcypromine;

substance concentrationmole/literM = 133,19 g/molNPU04291P—Tranylcypromine; subst.c.= ? prefix ? mol/l

Urine—Tranylcypromine;

substance concentrationmole/literM = 133,19 g/molNPU03608U—Tranylcypromine; subst.c.= ? prefix ? mol/l

Urine—Trenbolone;

arbitrary concentration(procedure)M = 270,38 g/molNPU04645U—Trenbolone; arb.c.(proc.) = ?

Urine—Trenbolone;

substance concentrationmole/literM = 270,38 g/molNPU04909U—Trenbolone; subst.c.= ? prefix ? mol/l

Urine—Triamterene;

arbitrary concentration(procedure)M = 253,26 g/molNPU04646U—Triamterene; arb.c.(proc.) = ?

Urine—Triamterene;

substance concentrationmicromole/literM = 253,26 g/molNPU03615U—Triamterene; subst.c. = ? µmol/l

Urine—Triazolam;

arbitrary concentration(procedure)M = 343,21 g/molNPU03616U—Triazolam; arb.c.(proc.) = ?


550 H. OLESEN

Urine—Triazolam;

substance concentrationmicromole/literM = 343,21 g/molNPU01634U—Triazolam; subst.c. = ? µmol/l

Plasma—Triazolam;

substance concentrationnanomole/literM = 343,21 g/molNPU08833P—Triazolam; subst.c. = ? nmol/l

Urine—Trifluoperazine;

arbitrary concentration(procedure)M = 407,50 g/molNPU04292U—Trifluoperazine; arb.c.(proc.) = ?

Urine—Trifluoperazine;

substance concentrationmole/literM = 407,50 g/molNPU04293U—Trifluoperazine; subst.c.= ? prefix ? mol/l

Plasma—Trifluoperazine;

substance concentrationnanomole/literM = 407,50 g/molNPU04294P—Trifluoperazine; subst.c. = ? nmol/l

Urine—Trimeperidine;

arbitrary concentration(procedure)M = 275,38 g/molNPU04647U—Trimeperidine; arb.c.(proc.) = ?

Urine—Trimeperidine;

substance concentrationmicromole/literM = 275,38 g/molNPU03628U—Trimeperidine; subst.c. = ? µmol/l

Plasma—Trimethadione;

substance concentrationmicromole/literM = 143,14 g/molNPU10234P—Trimethadione; subst.c. = ? µmol/l

Urine—Trimethoprim;

arbitrary concentration(procedure)M = 290,32 g/molNPU10243U—Trimethoprim; arb.c.(proc.) = ?

Plasma—Trimethoprim;

substance concentrationmicromole/literM = 290,32 g/molNPU08834P—Trimethoprim; subst.c. = ? µmol/l

Urine—Trimipramine;

arbitrary concentration(procedure)M = 294,42 g/molNPU09089U—Trimipramine; arb.c.(proc.) = ?

Plasma—Trimipramine;

substance concentrationnanomole/literM = 294,42 g/molNPU04869P—Trimipramine; subst.c. = ? nmol/l

Urine—Trimipramine;

substance concentrationnanomole/literM = 294,42 g/molNPU09088U—Trimipramine; subst.c. = ? nmol/l

Patient—Valproate(administered);

substance rate(oral administration)micromole/dayNote: M (anion) = 143,21 g/molNPU10256Pt—Valproate(administered); subst.rate(p.o.) = ?µmol/d

Plasma—Valproate;

substance concentrationmicromole/literNote: M (anion) = 143,21 g/molNPU03735P—Valproate; subst.c. = ? µmol/l

Urine—Valproate;

substance concentrationmicromole/literNote: M (anion) = 143,21 g/molNPU04649U—Valproate; subst.c. = ? µmol/l



Plasma—Vancomycin;

arbitrary concentration(procedure)NPU12368P—Vancomycin; arb.c.(proc.) = ?

Urine—Vancomycin;

arbitrary concentration(procedure)M = 1449,27 g/molNPU10240U—Vancomycin; arb.c.(proc.) = ?

Cerebrospinal fluid—Vancomycin;

substance concentrationmicromole/literNPU12931Csf—Vancomycin; subst.c. = ? µmol/l

Plasma—Vancomycin;

substance concentrationmicromole/literM = 1449,27 g/molNPU08731P—Vancomycin; subst.c. = ? µmol/l

Secretion(specification)—Vancomycin;

substance concentrationmicromole/literNPU12930Secr(spec.)—Vancomycin; subst.c. = ? µmol/l

System(specification)—Vancomycin;

substance concentrationmicromole/literNPU17529Syst(spec.)—Vancomycin; subst.c. = ? µmol/l

Urine—Vancomycin;

substance concentrationmicromole/literNPU12929U—Vancomycin; subst.c. = ? µmol/l

Urine—Venlafaxine;

arbitrary concentration(procedure)M = 277,41 g/molNPU09092U—Venlafaxine; arb.c.(proc.) = ?

Urine—Venlafaxine;

substance concentrationmole/literM = 277,41 g/molNPU09091U—Venlafaxine; subst.c.= ? prefix ? mol/l

Plasma—Venlafaxine;

substance concentrationnanomole/literM = 277,41 g/molNPU09090P—Venlafaxine; subst.c. = ? nmol/l

Plasma—Verapamil;

substance concentrationnanomole/literM = 454,61 g/molNPU08835P—Verapamil; subst.c. = ? nmol/l

Plasma—Vigabatrin;

substance concentrationmicromole/literNPU08966P—Vigabatrin; subst.c. = ? µmol/l

Plasma—Warfarin;

substance concentrationmole/literM = 308,33 g/molNPU08836P—Warfarin; subst.c.= ? prefix ? mol/l

Urine—Zolpidem;

arbitrary concentration(procedure)M = 307,40 g/molNPU09068U—Zolpidem; arb.c.(proc.) = ?

Plasma—Zolpidem;

substance concentrationmole/literM = 307,40 g/molNPU09066P—Zolpidem; subst.c.= ? prefix ? mol/l

Urine—Zolpidem;

substance concentration mole/literM = 307,40 g/molNPU09067U—Zolpidem; subst.c.= ? prefix ? mol/l


552 H. OLESEN

Urine—Zopiclone;

arbitrary concentration(procedure)M = 388,81 g/molNPU09070U—Zopiclone; arb.c.(proc.) = ?

Plasma—Zopiclone;

substance concentrationmole/literM = 388,81 g/molNPU08837P—Zopiclone; subst.c.= ? prefix ? mol/l

Urine—Zopiclone;

substance concentrationmole/literM = 388,81 g/molNPU09069U—Zopiclone; subst.c.= ? prefix ? mol/l

Patient—Zuclopenthixol(administered);

substance rate(oral administration)micromole/dayM = 400,97 g/molNPU10255Pt—Zuclopenthixol(administered); subst.rate(p.o.) =? µmol/d

Urine—Zuclopenthixol;

arbitrary concentration(procedure)M = 400,97 g/molOther term(s): ClopenthixolNPU01619U—Zuclopenthixol; arb.c.(proc.) = ?

Plasma—Zuclopenthixol;

substance concentrationnanomole/literM = 400,97 g/molOther term(s): ClopenthixolNPU03962P—Zuclopenthixol; subst.c. = ? nmol/l

Urine—Zuclopenthixol;

substance concentrationnanomole/literM = 400,97 g/molOther term(s): ClopenthixolNPU04840U—Zuclopenthixol; subst.c. = ? nmol/l

properties and units in the clinical...

Documents